NG1970的个人主页 - 老虎社区

NG1970

NG1970

暂无个人介绍

IP属地：未知

246关注

8粉丝

0主题

0勋章

2021-10-02

Like

Top 10 stocks that Wall Street’s picks for Q4

2021-10-08

True ?

Wall Street ends day with solid gains; investors hail U.S. debt-ceiling truce

2021-11-03

$SINGAPORE AIRLINES LTD(C6L.SI)$even 100% fly also hard to make profit at least 2yrs

2021-09-28

Like

Tech pulls Nasdaq to lower close as Treasury yields rise

2021-09-28

Like

Got $1,000? 3 Buffett Stocks to Buy and Hold Forever

2021-12-23

Like like like

抱歉，原内容已删除

2021-11-20

Like like like

抱歉，原内容已删除

2021-11-17

Very hard to select a good stock with good returns

抱歉，原内容已删除

2021-11-12

$Tiger Brokers(TIGR)$up up up

2021-10-08

High will be higer

Tesla Is on a Path to $400 Billion in Sales. Thank GM.

2021-11-05

$GENTING SINGAPORE LIMITED(G13.SI)$casino or resort

2021-11-17

Like like like

Palantir Stock: What’s Next as The Meme Crowd Follows Wall Street’s Lead?

2021-11-11

$CREATIVE TECHNOLOGY LTD(C76.SI)$was $60+ when everyone thought Mr Sim is talent

2021-11-02

$Apple(AAPL)$is this price a buy for long term?

2021-11-01

$Audience(1AZ.SI)$Malaysian stock listed in SGX market.

2021-10-27

$VIVIDTHREE HOLDINGS LTD.(OMK.SI)$crazy stock market

2021-10-25

$CH OFFSHORE LTD(C13.SI)$the stock related to Baker Tech. Both are oil and gas industry

2021-10-23

$CHINA STAR FOOD GROUP LIMITED(42W.SI)$waiting a announcement to push

2021-10-18

I am using their One Credit Card

2021-12-18

Like like like

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4094271228114110","uuid":"4094271228114110","gmtCreate":1631168485826,"gmtModify":1632793103634,"name":"NG1970","pinyin":"ng1970","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":8,"headSize":246,"tweetSize":129,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.44%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.34%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.26","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":698225846,"gmtCreate":1640414344891,"gmtModify":1640414345048,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"Post&nbsp;","listText":"Post&nbsp;","text":"Post","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698225846","repostId":"693654529","repostType":1,"repost":{"id":693654529,"gmtCreate":1640016490871,"gmtModify":1640042569156,"author":{"id":"3574968450404111","authorId":"3574968450404111","name":"B.God","avatar":"https://static.tigerbbs.com/8fba96cdefc2640a0413c00996aed28d","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574968450404111","authorIdStr":"3574968450404111"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Congrats to those who listen to my warning 3 weeks ago. I said it before and will say it again. Tesla is $400-500 stock in 2022 due to FED tapering and raising of interest rates. Institutions and smart money are unloading Tesla at the highs while only dummies retail investors&nbsp;catching their bags. =)","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Congrats to those who listen to my warning 3 weeks ago. I said it before and will say it again. Tesla is $400-500 stock in 2022 due to FED tapering and raising of interest rates. Institutions and smart money are unloading Tesla at the highs while only dummies retail investors&nbsp;catching their bags. =)","text":"$Tesla Motors(TSLA)$Congrats to those who listen to my warning 3 weeks ago. I said it before and will say it again. Tesla is $400-500 stock in 2022 due to FED tapering and raising of interest rates. Institutions and smart money are unloading Tesla at the highs while only dummies retail investors catching their bags. =)","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693654529","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1899,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691460142,"gmtCreate":1640228331608,"gmtModify":1640228331764,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"Like like like&nbsp;","listText":"Like like like&nbsp;","text":"Like like like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691460142","repostId":"1146715547","repostType":2,"isVote":1,"tweetType":1,"viewCount":1679,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699285322,"gmtCreate":1639811350806,"gmtModify":1639811350880,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"Like like like&nbsp;","listText":"Like like like&nbsp;","text":"Like like like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699285322","repostId":"2192677978","repostType":2,"repost":{"id":"2192677978","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639749246,"share":"https://ttm.financial/m/news/2192677978?lang=&edition=full","pubTime":"2021-12-17 21:54","market":"us","language":"en","title":"The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx","url":"https://stock-news.laohu8.com/highlight/detail?id=2192677978","media":"Benzinga","summary":"Here&#39;s a roundup of top developments in the biotech space over the last 24 hours.","content":"<html><body><p>Here's a roundup of top developments in the biotech space over the last 24 hours.</p>\n<h3>Stocks In Focus</h3>\n<h3>Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral COVID-19 Antiviral Treatment</h3>\n<p><strong>Merck &amp; Co., Inc. </strong>(NYSE:MRK) and Ridgeback Biotherapeutics announced the New England Journal of Medicines has published findings from the Phase 3 MOVe-OUT trial evaluating molnupiravir,  in non-hospitalized high risk adults with mild to moderate COVID-19, showing early treatment with molnupiravir significantly reduced the risk of hospitalization or death in high risk, unvaccinated adults with COVID-19.</p>\n<p>Separately, Merck said the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Keytruda as monotherapy for the adjuvant treatment of adults with renal cell carcinoma at increased risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions.</p>\n<p>Merck shares were rising 1.17% to $76.80 in premarket trading.</p>\n<h3>Lyell Announces FDA Clearance For Initiating Phase 1 Study Of Solid Tumor Investigational Therapy</h3>\n<p><strong><a href=\"https://laohu8.com/S/LYEL\">Lyell Immunopharma, Inc.</a> </strong>(NASDAQ:LYEL) announced the U.S. Food and Drug Administration has cleared its investigational new drug application to initiate a Phase 1 clinical trial for LYL797, its first therapeutic candidate incorporating T-cell reprogramming technologies for the treatment of solid tumors.</p>\n<p>Lyell said it expects to begin screening patients with relapsed/refractory triple-negative breast cancer, who have failed at least two lines of therapy by the end of the first quarter for the Phase 1 dose escalation phase of the trial and plans to expand the trial to include patients with non-small cell lung cancer when a recommended dose is determined.</p>\n<p>The stock was up 4.47% at $9.35 in premarket trading.</p>\n<p><em>Click  here  to access Benzinga's FDA Calendar</em></p>\n<h3>Allovir's Chief Medical Officer To Step Down</h3>\n<p><strong>AlloVir </strong>(NASDAQ:ALVR) announced that Augustin Melian, its chief medical officer, has decided to leave the company at the end of this year. Melian has agreed to work with AlloVir in an advisory capacity to ensure a smooth transition.</p>\n<p>Richard Riese, Senior Vice President, Clinical Research, will continue to lead the company's clinical development programs, including oversight of the Phase 3 studies for posoleucel, the company said.</p>\n<h3>Pfizer, BioNTech File For Expanding Approval Of COVID-19 Vaccine For Adolescents</h3>\n<p><strong>Pfizer, Inc. </strong>(NYSE:PFE) and<strong><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> </strong>(NASDAQ:BNTX) announced they have submitted a supplemental biologics license application to the FDA for expanding the approval of Comirnaty  to include individuals ages 12 through 15 years.</p>\n<h3>ObsEva Says EMA Committee Recommends Approval Of Uterine Fibroid Treatment</h3>\n<p><strong>ObsEva SA </strong>(NASDAQ:OBSV) announced EMA's CHMP adopted a positive opinion recommending approval of linzagolix, an oral GnRH antagonist for the management of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.</p>\n<p>The shares were up 6.39% to $2.33 in premarket trading.</p>\n<h3>Genfit Our-licenses Liver Disease Drug To Ispen, Sells Equity Stake to The French Biopharma</h3>\n<p><strong>GENFIT </strong>(NASDAQ:GNFT) and Ispen said they have entered into a long-term strategic partnership for a global collaboration between the two companies. The agreement gives Ipsen exclusive worldwide license to develop, manufacture and commercialize Genfit's investigational treatment elafibranor, for people living with primary biliary cholangitis.</p>\n<p>The partnership also gives Ipsen access to future clinical programs led by Genfit and combines Genfit's scientific expertise and proprietary technologies in liver disease with Ipsen's development and commercialization capabilities.</p>\n<p>Ipsen will also purchase newly issued Genfit equity representing 8% post-issuance through a 28-million-euro ($31.73 million) investment.</p>\n<p>Separately, Genfit announced the acquisition of exclusive rights from Genoscience Pharma to develop and commercialize the investigational treatment GNS561 in cholangiocarcinoma in the U.S. Canada and Europe, including the U.K. and Switzerland.</p>\n<p>Genfit shares were rising 42.77% to $4.74 in premarket trading.</p>\n<h3>Biogen's Aducanumab Receives Negative Opinion From EMA Committee</h3>\n<p><strong>Biogen, Inc. </strong>(NASDAQ:BIIB) and <strong>Eisai Co., Ltd. </strong>(PNK: ESALY) announced that EMA's CHMP has adopted a negative opinion on the marketing authorization application for aducanumab for the treatment of the early stages of Alzheimer's disease known as mild cognitive impairment due to Alzheimer's disease and mild Alzheimer's disease dementia. This decision is aligned to the negative trend vote of the committee in November 2021. Biogen said it will seek a re-examination of the opinion by the CHMP.</p>\n<p>The shares were down 1.92% to $230.99 in premarket trading.</p>\n<h3>CASI To Buy Back $10M Worth Of Shares</h3>\n<p><strong>CASI Pharmaceuticals, Inc. </strong>(NASDAQ:CASI) announced that its board of directors approved a stock repurchase program for the repurchase of up to $10 million of the common stock through open market purchases.</p>\n<p>The stock was up 3.25% to 79.50 in premarket trading.</p>\n<h3>Navidea Announces Commencement Of Late-Stage Study Of Imaging Agent to Predict Response In Rheumatoid Arthritis Patients</h3>\n<p><strong><a href=\"https://laohu8.com/S/NAVB\">Navidea Biopharmaceuticals</a>, Inc. </strong>(NYSE:NAVB) announced the launch of the NAV3-33 Phase 3 clinical trial, evaluating Tc99m tilmanocept imaging for the early prediction of anti-TNFα therapy response in patients with moderate to severe active rheumatoid arthritis.</p>\n<p>The stock was up 2.48% to $1.24 in premarket trading.</p>\n<p><em>Related Link:  Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates</em></p>\n<h3>On The Radar</h3>\n<h3>PDUFA Dates</h3>\n<p>The FDA is expected to rule on <strong>Intra-Cellular Therapies, Inc.'s </strong>(NASDAQ:ITCI) Caplyta for the expanded indication of bipolar disorder,</p>\n<p>The regulator is also due to give its verdict on <strong>argenx SE's </strong>(NASDAQ:ARGX) biologic license application for efgartigimod for the treatment of generalized myasthenia gravis.</p>\n<h3>Earnings</h3>\n<p><strong>Sonnet BioTherapeutics Holdings, Inc. </strong>(NASDAQ:SONN) (before the market open)</p>\n</body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-17 21:54</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Here's a roundup of top developments in the biotech space over the last 24 hours.</p>\n<h3>Stocks In Focus</h3>\n<h3>Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral COVID-19 Antiviral Treatment</h3>\n<p><strong>Merck &amp; Co., Inc. </strong>(NYSE:MRK) and Ridgeback Biotherapeutics announced the New England Journal of Medicines has published findings from the Phase 3 MOVe-OUT trial evaluating molnupiravir,  in non-hospitalized high risk adults with mild to moderate COVID-19, showing early treatment with molnupiravir significantly reduced the risk of hospitalization or death in high risk, unvaccinated adults with COVID-19.</p>\n<p>Separately, Merck said the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Keytruda as monotherapy for the adjuvant treatment of adults with renal cell carcinoma at increased risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions.</p>\n<p>Merck shares were rising 1.17% to $76.80 in premarket trading.</p>\n<h3>Lyell Announces FDA Clearance For Initiating Phase 1 Study Of Solid Tumor Investigational Therapy</h3>\n<p><strong><a href=\"https://laohu8.com/S/LYEL\">Lyell Immunopharma, Inc.</a> </strong>(NASDAQ:LYEL) announced the U.S. Food and Drug Administration has cleared its investigational new drug application to initiate a Phase 1 clinical trial for LYL797, its first therapeutic candidate incorporating T-cell reprogramming technologies for the treatment of solid tumors.</p>\n<p>Lyell said it expects to begin screening patients with relapsed/refractory triple-negative breast cancer, who have failed at least two lines of therapy by the end of the first quarter for the Phase 1 dose escalation phase of the trial and plans to expand the trial to include patients with non-small cell lung cancer when a recommended dose is determined.</p>\n<p>The stock was up 4.47% at $9.35 in premarket trading.</p>\n<p><em>Click  here  to access Benzinga's FDA Calendar</em></p>\n<h3>Allovir's Chief Medical Officer To Step Down</h3>\n<p><strong>AlloVir </strong>(NASDAQ:ALVR) announced that Augustin Melian, its chief medical officer, has decided to leave the company at the end of this year. Melian has agreed to work with AlloVir in an advisory capacity to ensure a smooth transition.</p>\n<p>Richard Riese, Senior Vice President, Clinical Research, will continue to lead the company's clinical development programs, including oversight of the Phase 3 studies for posoleucel, the company said.</p>\n<h3>Pfizer, BioNTech File For Expanding Approval Of COVID-19 Vaccine For Adolescents</h3>\n<p><strong>Pfizer, Inc. </strong>(NYSE:PFE) and<strong><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> </strong>(NASDAQ:BNTX) announced they have submitted a supplemental biologics license application to the FDA for expanding the approval of Comirnaty  to include individuals ages 12 through 15 years.</p>\n<h3>ObsEva Says EMA Committee Recommends Approval Of Uterine Fibroid Treatment</h3>\n<p><strong>ObsEva SA </strong>(NASDAQ:OBSV) announced EMA's CHMP adopted a positive opinion recommending approval of linzagolix, an oral GnRH antagonist for the management of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.</p>\n<p>The shares were up 6.39% to $2.33 in premarket trading.</p>\n<h3>Genfit Our-licenses Liver Disease Drug To Ispen, Sells Equity Stake to The French Biopharma</h3>\n<p><strong>GENFIT </strong>(NASDAQ:GNFT) and Ispen said they have entered into a long-term strategic partnership for a global collaboration between the two companies. The agreement gives Ipsen exclusive worldwide license to develop, manufacture and commercialize Genfit's investigational treatment elafibranor, for people living with primary biliary cholangitis.</p>\n<p>The partnership also gives Ipsen access to future clinical programs led by Genfit and combines Genfit's scientific expertise and proprietary technologies in liver disease with Ipsen's development and commercialization capabilities.</p>\n<p>Ipsen will also purchase newly issued Genfit equity representing 8% post-issuance through a 28-million-euro ($31.73 million) investment.</p>\n<p>Separately, Genfit announced the acquisition of exclusive rights from Genoscience Pharma to develop and commercialize the investigational treatment GNS561 in cholangiocarcinoma in the U.S. Canada and Europe, including the U.K. and Switzerland.</p>\n<p>Genfit shares were rising 42.77% to $4.74 in premarket trading.</p>\n<h3>Biogen's Aducanumab Receives Negative Opinion From EMA Committee</h3>\n<p><strong>Biogen, Inc. </strong>(NASDAQ:BIIB) and <strong>Eisai Co., Ltd. </strong>(PNK: ESALY) announced that EMA's CHMP has adopted a negative opinion on the marketing authorization application for aducanumab for the treatment of the early stages of Alzheimer's disease known as mild cognitive impairment due to Alzheimer's disease and mild Alzheimer's disease dementia. This decision is aligned to the negative trend vote of the committee in November 2021. Biogen said it will seek a re-examination of the opinion by the CHMP.</p>\n<p>The shares were down 1.92% to $230.99 in premarket trading.</p>\n<h3>CASI To Buy Back $10M Worth Of Shares</h3>\n<p><strong>CASI Pharmaceuticals, Inc. </strong>(NASDAQ:CASI) announced that its board of directors approved a stock repurchase program for the repurchase of up to $10 million of the common stock through open market purchases.</p>\n<p>The stock was up 3.25% to 79.50 in premarket trading.</p>\n<h3>Navidea Announces Commencement Of Late-Stage Study Of Imaging Agent to Predict Response In Rheumatoid Arthritis Patients</h3>\n<p><strong><a href=\"https://laohu8.com/S/NAVB\">Navidea Biopharmaceuticals</a>, Inc. </strong>(NYSE:NAVB) announced the launch of the NAV3-33 Phase 3 clinical trial, evaluating Tc99m tilmanocept imaging for the early prediction of anti-TNFα therapy response in patients with moderate to severe active rheumatoid arthritis.</p>\n<p>The stock was up 2.48% to $1.24 in premarket trading.</p>\n<p><em>Related Link:  Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates</em></p>\n<h3>On The Radar</h3>\n<h3>PDUFA Dates</h3>\n<p>The FDA is expected to rule on <strong>Intra-Cellular Therapies, Inc.'s </strong>(NASDAQ:ITCI) Caplyta for the expanded indication of bipolar disorder,</p>\n<p>The regulator is also due to give its verdict on <strong>argenx SE's </strong>(NASDAQ:ARGX) biologic license application for efgartigimod for the treatment of generalized myasthenia gravis.</p>\n<h3>Earnings</h3>\n<p><strong>Sonnet BioTherapeutics Holdings, Inc. </strong>(NASDAQ:SONN) (before the market open)</p>\n</body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CASI":"凯信远达","BK4139":"生物科技","MRK":"默沙东","GNFTF":"Genfit","NAVB":"Navidea生物制药","BNTX":"BioNTech SE","ARGX":"Argenx SE","IBB":"生物科技指数ETF-iShares Nasdaq","SONN":"Sonnet BioTherapeutics Holdings, Inc.","BIIB":"渤健公司","ITCI":"Intra-Cellular Therapies Inc.","PFE":"辉瑞","LYEL":"Lyell Immunopharma, Inc.","GNFT":"Genfit S.A."},"source_url":"https://www.benzinga.com/general/biotech/21/12/24666393/the-daily-biotech-pulse-genfit-spikes-on-liver-disease-drug-licensing-deal-lyell-gets-nod-for-sol","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192677978","content_text":"Here's a roundup of top developments in the biotech space over the last 24 hours.\nStocks In Focus\nMerck Announces Publication Of Positive Data From Late-Stage Study Of Oral COVID-19 Antiviral Treatment\nMerck & Co., Inc. (NYSE:MRK) and Ridgeback Biotherapeutics announced the New England Journal of Medicines has published findings from the Phase 3 MOVe-OUT trial evaluating molnupiravir,  in non-hospitalized high risk adults with mild to moderate COVID-19, showing early treatment with molnupiravir significantly reduced the risk of hospitalization or death in high risk, unvaccinated adults with COVID-19.\nSeparately, Merck said the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Keytruda as monotherapy for the adjuvant treatment of adults with renal cell carcinoma at increased risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions.\nMerck shares were rising 1.17% to $76.80 in premarket trading.\nLyell Announces FDA Clearance For Initiating Phase 1 Study Of Solid Tumor Investigational Therapy\nLyell Immunopharma, Inc. (NASDAQ:LYEL) announced the U.S. Food and Drug Administration has cleared its investigational new drug application to initiate a Phase 1 clinical trial for LYL797, its first therapeutic candidate incorporating T-cell reprogramming technologies for the treatment of solid tumors.\nLyell said it expects to begin screening patients with relapsed/refractory triple-negative breast cancer, who have failed at least two lines of therapy by the end of the first quarter for the Phase 1 dose escalation phase of the trial and plans to expand the trial to include patients with non-small cell lung cancer when a recommended dose is determined.\nThe stock was up 4.47% at $9.35 in premarket trading.\nClick  here  to access Benzinga's FDA Calendar\nAllovir's Chief Medical Officer To Step Down\nAlloVir (NASDAQ:ALVR) announced that Augustin Melian, its chief medical officer, has decided to leave the company at the end of this year. Melian has agreed to work with AlloVir in an advisory capacity to ensure a smooth transition.\nRichard Riese, Senior Vice President, Clinical Research, will continue to lead the company's clinical development programs, including oversight of the Phase 3 studies for posoleucel, the company said.\nPfizer, BioNTech File For Expanding Approval Of COVID-19 Vaccine For Adolescents\nPfizer, Inc. (NYSE:PFE) andBioNTech SE (NASDAQ:BNTX) announced they have submitted a supplemental biologics license application to the FDA for expanding the approval of Comirnaty  to include individuals ages 12 through 15 years.\nObsEva Says EMA Committee Recommends Approval Of Uterine Fibroid Treatment\nObsEva SA (NASDAQ:OBSV) announced EMA's CHMP adopted a positive opinion recommending approval of linzagolix, an oral GnRH antagonist for the management of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.\nThe shares were up 6.39% to $2.33 in premarket trading.\nGenfit Our-licenses Liver Disease Drug To Ispen, Sells Equity Stake to The French Biopharma\nGENFIT (NASDAQ:GNFT) and Ispen said they have entered into a long-term strategic partnership for a global collaboration between the two companies. The agreement gives Ipsen exclusive worldwide license to develop, manufacture and commercialize Genfit's investigational treatment elafibranor, for people living with primary biliary cholangitis.\nThe partnership also gives Ipsen access to future clinical programs led by Genfit and combines Genfit's scientific expertise and proprietary technologies in liver disease with Ipsen's development and commercialization capabilities.\nIpsen will also purchase newly issued Genfit equity representing 8% post-issuance through a 28-million-euro ($31.73 million) investment.\nSeparately, Genfit announced the acquisition of exclusive rights from Genoscience Pharma to develop and commercialize the investigational treatment GNS561 in cholangiocarcinoma in the U.S. Canada and Europe, including the U.K. and Switzerland.\nGenfit shares were rising 42.77% to $4.74 in premarket trading.\nBiogen's Aducanumab Receives Negative Opinion From EMA Committee\nBiogen, Inc. (NASDAQ:BIIB) and Eisai Co., Ltd. (PNK: ESALY) announced that EMA's CHMP has adopted a negative opinion on the marketing authorization application for aducanumab for the treatment of the early stages of Alzheimer's disease known as mild cognitive impairment due to Alzheimer's disease and mild Alzheimer's disease dementia. This decision is aligned to the negative trend vote of the committee in November 2021. Biogen said it will seek a re-examination of the opinion by the CHMP.\nThe shares were down 1.92% to $230.99 in premarket trading.\nCASI To Buy Back $10M Worth Of Shares\nCASI Pharmaceuticals, Inc. (NASDAQ:CASI) announced that its board of directors approved a stock repurchase program for the repurchase of up to $10 million of the common stock through open market purchases.\nThe stock was up 3.25% to 79.50 in premarket trading.\nNavidea Announces Commencement Of Late-Stage Study Of Imaging Agent to Predict Response In Rheumatoid Arthritis Patients\nNavidea Biopharmaceuticals, Inc. (NYSE:NAVB) announced the launch of the NAV3-33 Phase 3 clinical trial, evaluating Tc99m tilmanocept imaging for the early prediction of anti-TNFα therapy response in patients with moderate to severe active rheumatoid arthritis.\nThe stock was up 2.48% to $1.24 in premarket trading.\nRelated Link:  Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates\nOn The Radar\nPDUFA Dates\nThe FDA is expected to rule on Intra-Cellular Therapies, Inc.'s (NASDAQ:ITCI) Caplyta for the expanded indication of bipolar disorder,\nThe regulator is also due to give its verdict on argenx SE's (NASDAQ:ARGX) biologic license application for efgartigimod for the treatment of generalized myasthenia gravis.\nEarnings\nSonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (before the market open)","news_type":1,"symbols_score_info":{"ALVR":0.9,"ARGX":0.9,"BIIB":0.9,"BNTX":0.9,"CASI":0.9,"GNFT":0.9,"GNFTF":1,"IBB":0.9,"ITCI":0.9,"LYEL":0.9,"MRK":0.9,"NAVB":0.9,"OBSV":0.9,"PFE":0.9,"SONN":0.9}},"isVote":1,"tweetType":1,"viewCount":1549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699282710,"gmtCreate":1639811297418,"gmtModify":1639811297567,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699282710","repostId":"2192750849","repostType":2,"repost":{"id":"2192750849","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639757948,"share":"https://ttm.financial/m/news/2192750849?lang=&edition=full","pubTime":"2021-12-18 00:19","market":"hk","language":"en","title":"Mid-Morning Market Update: Markets Open Lower; Darden Restaurants Posts Upbeat Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2192750849","media":"Benzinga","summary":"Following the market opening Friday, the Dow traded down 1.33% to 35,420.19 while the NASDAQ fell 0.61% to 15,082.68. The S&amp;P also fell, dropping 1% to 4,622.16.","content":"<html><body><p>Following the market opening Friday, the Dow traded down 1.33% to 35,420.19 while the NASDAQ fell 0.61% to 15,082.68. The S&amp;P also fell, dropping 1% to 4,622.16.</p>\n<p>The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 51,435,650 cases with around 824,520 deaths. India confirmed a total of at least 34,726,040 cases and 476,860 deaths, while Brazil reported over 22,204,940 COVID-19 cases with 617,520 deaths. In total, there were at least 273,330,020 cases of COVID-19 worldwide with more than 5,355,740 deaths.</p>\n<p>\n<strong>Leading and Lagging Sectors</strong></p>\n<p>\r\nReal estate shares climbed 0.1% on Friday. Meanwhile, top gainers in the sector included <strong> InvenTrust Properties Corp. </strong> (NYSE:IVT), up 3% and <strong> CatchMark Timber Trust, Inc. </strong> (NYSE:CTT) up 3%.</p>\n<p>\r\nIn trading on Friday, financial shares fell 2.4%.</p>\n<p>\n<strong>Top Headline</strong></p>\n<p>\n<strong>Darden Restaurants, Inc. </strong> (NYSE:DRI) reported better-than-expected earnings for its second quarter and raised its FY22 sales guidance.</p>\n<p>Darden reported quarterly earnings of $1.48 per share, beating analysts’ estimates of $1.43 per share. The company’s quarterly sales came in at $2.27 billion, versus expectations of $2.23 billion.</p>\n<p>Darden raised its FY22 sales guidance from $9.4 billion-$9.6 billion to $9.55 billion-$9.7 billion. The company said Chairman and CEO Gene Lee will retire in May 2022 and named President and CFO Rick Cardenas as his replacement.</p>\n<p><strong>Equities Trading UP</strong></p>\n<p>\n<strong>Genfit SA </strong> (NASDAQ:GNFT) shares shot up 46% to $4.83 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor.</p>\n<p>\r\nShares of <strong> <a href=\"https://laohu8.com/S/BLPH\">Bellerophon Therapeutics, Inc.</a> </strong> (NASDAQ:BLPH) got a boost, shooting 34% to $3.1694 after topline data from Phase 2 study (PULSE-PHPF-002) evaluating the acute hemodynamic benefit of INOpulse via right heart catheterization for pulmonary hypertension associated with sarcoidosis (PH-Sarc).</p>\n<p>\n<strong>X4 Pharmaceuticals, Inc. </strong> (NASDAQ:XFOR) shares were also up, gaining 27% to $3.0087.</p>\n<p>\n<em>Check out these big movers of the day</em></p>\n<p>\n<strong>Equities Trading DOWN</strong></p>\n<p><strong><a href=\"https://laohu8.com/S/BKSY\">BlackSky Technology Inc.</a> </strong> (NYSE:BKSY) shares tumbled 15% to $5.97.</p>\n<p>\r\nShares of <strong> <a href=\"https://laohu8.com/S/RIVN\">Rivian Automotive, Inc.</a> </strong> (NASDAQ:RIVN) were down 14% to $93.62 after the company reported Q3 earnings results and said it expects to be a few hundred vehicles short of its 2021 production target of 1,200 vehicles.</p>\n<p>\n<strong><a href=\"https://laohu8.com/S/TYRA\">Tyra Biosciences, Inc.</a> </strong> (NASDAQ:TYRA) was down, falling 12% to $12.15.</p>\n<p>\n<strong>Commodities</strong></p>\n<p>In commodity news, oil traded down 2% to $70.94, while gold traded up 0.6% to $1,808.70.</p>\n<p>\r\nSilver traded up 0.4% Friday to $22.58 while copper rose 0.4% to $4.3210.</p>\n<p>\n<strong>Euro zone</strong></p>\n<p>European shares were mostly lower today. The eurozone’s STOXX 600 declined 0.8%, the Spanish Ibex Index fell 0.8% and the German DAX 30 dropped 0.8%. Meanwhile, the London’s FTSE 100 gained 0.1%, French CAC 40 fell 0.9% and Italy’s FTSE MIB dipped 1.1%.</p>\n<p>The annual inflation rate in the Eurozone accelerated to 4.9% in November from 4.1% in the previous month, while construction output increased 4.4% year-over-year in October. Spain's trade deficit widened to EUR 3.4 billion in October from EUR 0.7 billion in the year-ago month.</p>\n<p>The Ifo Business Climate indicator for Germany dropped to 94.7 in December, while German producer prices surged 19.2% year-over-year in November, following an 18.4% growth in the prior month. Retail sales in the UK increased 1.4% in November. Passenger car registrations in the European Union dipped 20.5% year-over-year to 713,346 units in November.</p>\n<p>\n<strong>Economics</strong></p>\n<p>\r\nThe Baker Hughes North American rig count report for the latest week is scheduled for release at 1:00 p.m. ET.</p>\n<p>\r\nSan Francisco Federal Reserve President Mary Daly is set to speak at 1:00 p.m. ET.</p>\n<p>\r\nFederal Reserve Governor Christopher Waller will speak at 1:00 p.m. ET.</p>\n<p><em>Check out the full economic calendar here </em>\n</p>\n</body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mid-Morning Market Update: Markets Open Lower; Darden Restaurants Posts Upbeat Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMid-Morning Market Update: Markets Open Lower; Darden Restaurants Posts Upbeat Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-18 00:19</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Following the market opening Friday, the Dow traded down 1.33% to 35,420.19 while the NASDAQ fell 0.61% to 15,082.68. The S&amp;P also fell, dropping 1% to 4,622.16.</p>\n<p>The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 51,435,650 cases with around 824,520 deaths. India confirmed a total of at least 34,726,040 cases and 476,860 deaths, while Brazil reported over 22,204,940 COVID-19 cases with 617,520 deaths. In total, there were at least 273,330,020 cases of COVID-19 worldwide with more than 5,355,740 deaths.</p>\n<p>\n<strong>Leading and Lagging Sectors</strong></p>\n<p>\r\nReal estate shares climbed 0.1% on Friday. Meanwhile, top gainers in the sector included <strong> InvenTrust Properties Corp. </strong> (NYSE:IVT), up 3% and <strong> CatchMark Timber Trust, Inc. </strong> (NYSE:CTT) up 3%.</p>\n<p>\r\nIn trading on Friday, financial shares fell 2.4%.</p>\n<p>\n<strong>Top Headline</strong></p>\n<p>\n<strong>Darden Restaurants, Inc. </strong> (NYSE:DRI) reported better-than-expected earnings for its second quarter and raised its FY22 sales guidance.</p>\n<p>Darden reported quarterly earnings of $1.48 per share, beating analysts’ estimates of $1.43 per share. The company’s quarterly sales came in at $2.27 billion, versus expectations of $2.23 billion.</p>\n<p>Darden raised its FY22 sales guidance from $9.4 billion-$9.6 billion to $9.55 billion-$9.7 billion. The company said Chairman and CEO Gene Lee will retire in May 2022 and named President and CFO Rick Cardenas as his replacement.</p>\n<p><strong>Equities Trading UP</strong></p>\n<p>\n<strong>Genfit SA </strong> (NASDAQ:GNFT) shares shot up 46% to $4.83 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor.</p>\n<p>\r\nShares of <strong> <a href=\"https://laohu8.com/S/BLPH\">Bellerophon Therapeutics, Inc.</a> </strong> (NASDAQ:BLPH) got a boost, shooting 34% to $3.1694 after topline data from Phase 2 study (PULSE-PHPF-002) evaluating the acute hemodynamic benefit of INOpulse via right heart catheterization for pulmonary hypertension associated with sarcoidosis (PH-Sarc).</p>\n<p>\n<strong>X4 Pharmaceuticals, Inc. </strong> (NASDAQ:XFOR) shares were also up, gaining 27% to $3.0087.</p>\n<p>\n<em>Check out these big movers of the day</em></p>\n<p>\n<strong>Equities Trading DOWN</strong></p>\n<p><strong><a href=\"https://laohu8.com/S/BKSY\">BlackSky Technology Inc.</a> </strong> (NYSE:BKSY) shares tumbled 15% to $5.97.</p>\n<p>\r\nShares of <strong> <a href=\"https://laohu8.com/S/RIVN\">Rivian Automotive, Inc.</a> </strong> (NASDAQ:RIVN) were down 14% to $93.62 after the company reported Q3 earnings results and said it expects to be a few hundred vehicles short of its 2021 production target of 1,200 vehicles.</p>\n<p>\n<strong><a href=\"https://laohu8.com/S/TYRA\">Tyra Biosciences, Inc.</a> </strong> (NASDAQ:TYRA) was down, falling 12% to $12.15.</p>\n<p>\n<strong>Commodities</strong></p>\n<p>In commodity news, oil traded down 2% to $70.94, while gold traded up 0.6% to $1,808.70.</p>\n<p>\r\nSilver traded up 0.4% Friday to $22.58 while copper rose 0.4% to $4.3210.</p>\n<p>\n<strong>Euro zone</strong></p>\n<p>European shares were mostly lower today. The eurozone’s STOXX 600 declined 0.8%, the Spanish Ibex Index fell 0.8% and the German DAX 30 dropped 0.8%. Meanwhile, the London’s FTSE 100 gained 0.1%, French CAC 40 fell 0.9% and Italy’s FTSE MIB dipped 1.1%.</p>\n<p>The annual inflation rate in the Eurozone accelerated to 4.9% in November from 4.1% in the previous month, while construction output increased 4.4% year-over-year in October. Spain's trade deficit widened to EUR 3.4 billion in October from EUR 0.7 billion in the year-ago month.</p>\n<p>The Ifo Business Climate indicator for Germany dropped to 94.7 in December, while German producer prices surged 19.2% year-over-year in November, following an 18.4% growth in the prior month. Retail sales in the UK increased 1.4% in November. Passenger car registrations in the European Union dipped 20.5% year-over-year to 713,346 units in November.</p>\n<p>\n<strong>Economics</strong></p>\n<p>\r\nThe Baker Hughes North American rig count report for the latest week is scheduled for release at 1:00 p.m. ET.</p>\n<p>\r\nSan Francisco Federal Reserve President Mary Daly is set to speak at 1:00 p.m. ET.</p>\n<p>\r\nFederal Reserve Governor Christopher Waller will speak at 1:00 p.m. ET.</p>\n<p><em>Check out the full economic calendar here </em>\n</p>\n</body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DRI":"达登饭店","BKSY":"BlackSky Technology Inc.","IVT":"Inventrust Properties Corp.","GNFT":"Genfit S.A.","RIVN":"Rivian Automotive, Inc.","TYRA":"Tyra Biosciences, Inc.","XFOR":"X4制药"},"source_url":"https://www.benzinga.com/news/earnings/21/12/24671030/mid-morning-market-update-markets-open-lower-darden-restaurants-posts-upbeat-earnings","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192750849","content_text":"Following the market opening Friday, the Dow traded down 1.33% to 35,420.19 while the NASDAQ fell 0.61% to 15,082.68. The S&P also fell, dropping 1% to 4,622.16.\nThe U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 51,435,650 cases with around 824,520 deaths. India confirmed a total of at least 34,726,040 cases and 476,860 deaths, while Brazil reported over 22,204,940 COVID-19 cases with 617,520 deaths. In total, there were at least 273,330,020 cases of COVID-19 worldwide with more than 5,355,740 deaths.\n\nLeading and Lagging Sectors\n\r\nReal estate shares climbed 0.1% on Friday. Meanwhile, top gainers in the sector included  InvenTrust Properties Corp.  (NYSE:IVT), up 3% and  CatchMark Timber Trust, Inc.  (NYSE:CTT) up 3%.\n\r\nIn trading on Friday, financial shares fell 2.4%.\n\nTop Headline\n\nDarden Restaurants, Inc.  (NYSE:DRI) reported better-than-expected earnings for its second quarter and raised its FY22 sales guidance.\nDarden reported quarterly earnings of $1.48 per share, beating analysts’ estimates of $1.43 per share. The company’s quarterly sales came in at $2.27 billion, versus expectations of $2.23 billion.\nDarden raised its FY22 sales guidance from $9.4 billion-$9.6 billion to $9.55 billion-$9.7 billion. The company said Chairman and CEO Gene Lee will retire in May 2022 and named President and CFO Rick Cardenas as his replacement.\nEquities Trading UP\n\nGenfit SA  (NASDAQ:GNFT) shares shot up 46% to $4.83 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor.\n\r\nShares of  Bellerophon Therapeutics, Inc.  (NASDAQ:BLPH) got a boost, shooting 34% to $3.1694 after topline data from Phase 2 study (PULSE-PHPF-002) evaluating the acute hemodynamic benefit of INOpulse via right heart catheterization for pulmonary hypertension associated with sarcoidosis (PH-Sarc).\n\nX4 Pharmaceuticals, Inc.  (NASDAQ:XFOR) shares were also up, gaining 27% to $3.0087.\n\nCheck out these big movers of the day\n\nEquities Trading DOWN\nBlackSky Technology Inc.  (NYSE:BKSY) shares tumbled 15% to $5.97.\n\r\nShares of  Rivian Automotive, Inc.  (NASDAQ:RIVN) were down 14% to $93.62 after the company reported Q3 earnings results and said it expects to be a few hundred vehicles short of its 2021 production target of 1,200 vehicles.\n\nTyra Biosciences, Inc.  (NASDAQ:TYRA) was down, falling 12% to $12.15.\n\nCommodities\nIn commodity news, oil traded down 2% to $70.94, while gold traded up 0.6% to $1,808.70.\n\r\nSilver traded up 0.4% Friday to $22.58 while copper rose 0.4% to $4.3210.\n\nEuro zone\nEuropean shares were mostly lower today. The eurozone’s STOXX 600 declined 0.8%, the Spanish Ibex Index fell 0.8% and the German DAX 30 dropped 0.8%. Meanwhile, the London’s FTSE 100 gained 0.1%, French CAC 40 fell 0.9% and Italy’s FTSE MIB dipped 1.1%.\nThe annual inflation rate in the Eurozone accelerated to 4.9% in November from 4.1% in the previous month, while construction output increased 4.4% year-over-year in October. Spain's trade deficit widened to EUR 3.4 billion in October from EUR 0.7 billion in the year-ago month.\nThe Ifo Business Climate indicator for Germany dropped to 94.7 in December, while German producer prices surged 19.2% year-over-year in November, following an 18.4% growth in the prior month. Retail sales in the UK increased 1.4% in November. Passenger car registrations in the European Union dipped 20.5% year-over-year to 713,346 units in November.\n\nEconomics\n\r\nThe Baker Hughes North American rig count report for the latest week is scheduled for release at 1:00 p.m. ET.\n\r\nSan Francisco Federal Reserve President Mary Daly is set to speak at 1:00 p.m. ET.\n\r\nFederal Reserve Governor Christopher Waller will speak at 1:00 p.m. ET.\nCheck out the full economic calendar here","news_type":1,"symbols_score_info":{"BKSY":0.9,"BLPH":0.9,"CTT":0.9,"DRI":1,"GNFT":0.9,"IVT":0.9,"RIVN":0.9,"TYRA":0.9,"XFOR":0.9}},"isVote":1,"tweetType":1,"viewCount":1749,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699282926,"gmtCreate":1639811108664,"gmtModify":1639811108812,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"Like like like&nbsp;","listText":"Like like like&nbsp;","text":"Like like like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699282926","repostId":"2192750849","repostType":2,"repost":{"id":"2192750849","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639757948,"share":"https://ttm.financial/m/news/2192750849?lang=&edition=full","pubTime":"2021-12-18 00:19","market":"hk","language":"en","title":"Mid-Morning Market Update: Markets Open Lower; Darden Restaurants Posts Upbeat Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2192750849","media":"Benzinga","summary":"Following the market opening Friday, the Dow traded down 1.33% to 35,420.19 while the NASDAQ fell 0.61% to 15,082.68. The S&amp;P also fell, dropping 1% to 4,622.16.","content":"<html><body><p>Following the market opening Friday, the Dow traded down 1.33% to 35,420.19 while the NASDAQ fell 0.61% to 15,082.68. The S&amp;P also fell, dropping 1% to 4,622.16.</p>\n<p>The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 51,435,650 cases with around 824,520 deaths. India confirmed a total of at least 34,726,040 cases and 476,860 deaths, while Brazil reported over 22,204,940 COVID-19 cases with 617,520 deaths. In total, there were at least 273,330,020 cases of COVID-19 worldwide with more than 5,355,740 deaths.</p>\n<p>\n<strong>Leading and Lagging Sectors</strong></p>\n<p>\r\nReal estate shares climbed 0.1% on Friday. Meanwhile, top gainers in the sector included <strong> InvenTrust Properties Corp. </strong> (NYSE:IVT), up 3% and <strong> CatchMark Timber Trust, Inc. </strong> (NYSE:CTT) up 3%.</p>\n<p>\r\nIn trading on Friday, financial shares fell 2.4%.</p>\n<p>\n<strong>Top Headline</strong></p>\n<p>\n<strong>Darden Restaurants, Inc. </strong> (NYSE:DRI) reported better-than-expected earnings for its second quarter and raised its FY22 sales guidance.</p>\n<p>Darden reported quarterly earnings of $1.48 per share, beating analysts’ estimates of $1.43 per share. The company’s quarterly sales came in at $2.27 billion, versus expectations of $2.23 billion.</p>\n<p>Darden raised its FY22 sales guidance from $9.4 billion-$9.6 billion to $9.55 billion-$9.7 billion. The company said Chairman and CEO Gene Lee will retire in May 2022 and named President and CFO Rick Cardenas as his replacement.</p>\n<p><strong>Equities Trading UP</strong></p>\n<p>\n<strong>Genfit SA </strong> (NASDAQ:GNFT) shares shot up 46% to $4.83 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor.</p>\n<p>\r\nShares of <strong> <a href=\"https://laohu8.com/S/BLPH\">Bellerophon Therapeutics, Inc.</a> </strong> (NASDAQ:BLPH) got a boost, shooting 34% to $3.1694 after topline data from Phase 2 study (PULSE-PHPF-002) evaluating the acute hemodynamic benefit of INOpulse via right heart catheterization for pulmonary hypertension associated with sarcoidosis (PH-Sarc).</p>\n<p>\n<strong>X4 Pharmaceuticals, Inc. </strong> (NASDAQ:XFOR) shares were also up, gaining 27% to $3.0087.</p>\n<p>\n<em>Check out these big movers of the day</em></p>\n<p>\n<strong>Equities Trading DOWN</strong></p>\n<p><strong><a href=\"https://laohu8.com/S/BKSY\">BlackSky Technology Inc.</a> </strong> (NYSE:BKSY) shares tumbled 15% to $5.97.</p>\n<p>\r\nShares of <strong> <a href=\"https://laohu8.com/S/RIVN\">Rivian Automotive, Inc.</a> </strong> (NASDAQ:RIVN) were down 14% to $93.62 after the company reported Q3 earnings results and said it expects to be a few hundred vehicles short of its 2021 production target of 1,200 vehicles.</p>\n<p>\n<strong><a href=\"https://laohu8.com/S/TYRA\">Tyra Biosciences, Inc.</a> </strong> (NASDAQ:TYRA) was down, falling 12% to $12.15.</p>\n<p>\n<strong>Commodities</strong></p>\n<p>In commodity news, oil traded down 2% to $70.94, while gold traded up 0.6% to $1,808.70.</p>\n<p>\r\nSilver traded up 0.4% Friday to $22.58 while copper rose 0.4% to $4.3210.</p>\n<p>\n<strong>Euro zone</strong></p>\n<p>European shares were mostly lower today. The eurozone’s STOXX 600 declined 0.8%, the Spanish Ibex Index fell 0.8% and the German DAX 30 dropped 0.8%. Meanwhile, the London’s FTSE 100 gained 0.1%, French CAC 40 fell 0.9% and Italy’s FTSE MIB dipped 1.1%.</p>\n<p>The annual inflation rate in the Eurozone accelerated to 4.9% in November from 4.1% in the previous month, while construction output increased 4.4% year-over-year in October. Spain's trade deficit widened to EUR 3.4 billion in October from EUR 0.7 billion in the year-ago month.</p>\n<p>The Ifo Business Climate indicator for Germany dropped to 94.7 in December, while German producer prices surged 19.2% year-over-year in November, following an 18.4% growth in the prior month. Retail sales in the UK increased 1.4% in November. Passenger car registrations in the European Union dipped 20.5% year-over-year to 713,346 units in November.</p>\n<p>\n<strong>Economics</strong></p>\n<p>\r\nThe Baker Hughes North American rig count report for the latest week is scheduled for release at 1:00 p.m. ET.</p>\n<p>\r\nSan Francisco Federal Reserve President Mary Daly is set to speak at 1:00 p.m. ET.</p>\n<p>\r\nFederal Reserve Governor Christopher Waller will speak at 1:00 p.m. ET.</p>\n<p><em>Check out the full economic calendar here </em>\n</p>\n</body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mid-Morning Market Update: Markets Open Lower; Darden Restaurants Posts Upbeat Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMid-Morning Market Update: Markets Open Lower; Darden Restaurants Posts Upbeat Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-18 00:19</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Following the market opening Friday, the Dow traded down 1.33% to 35,420.19 while the NASDAQ fell 0.61% to 15,082.68. The S&amp;P also fell, dropping 1% to 4,622.16.</p>\n<p>The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 51,435,650 cases with around 824,520 deaths. India confirmed a total of at least 34,726,040 cases and 476,860 deaths, while Brazil reported over 22,204,940 COVID-19 cases with 617,520 deaths. In total, there were at least 273,330,020 cases of COVID-19 worldwide with more than 5,355,740 deaths.</p>\n<p>\n<strong>Leading and Lagging Sectors</strong></p>\n<p>\r\nReal estate shares climbed 0.1% on Friday. Meanwhile, top gainers in the sector included <strong> InvenTrust Properties Corp. </strong> (NYSE:IVT), up 3% and <strong> CatchMark Timber Trust, Inc. </strong> (NYSE:CTT) up 3%.</p>\n<p>\r\nIn trading on Friday, financial shares fell 2.4%.</p>\n<p>\n<strong>Top Headline</strong></p>\n<p>\n<strong>Darden Restaurants, Inc. </strong> (NYSE:DRI) reported better-than-expected earnings for its second quarter and raised its FY22 sales guidance.</p>\n<p>Darden reported quarterly earnings of $1.48 per share, beating analysts’ estimates of $1.43 per share. The company’s quarterly sales came in at $2.27 billion, versus expectations of $2.23 billion.</p>\n<p>Darden raised its FY22 sales guidance from $9.4 billion-$9.6 billion to $9.55 billion-$9.7 billion. The company said Chairman and CEO Gene Lee will retire in May 2022 and named President and CFO Rick Cardenas as his replacement.</p>\n<p><strong>Equities Trading UP</strong></p>\n<p>\n<strong>Genfit SA </strong> (NASDAQ:GNFT) shares shot up 46% to $4.83 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor.</p>\n<p>\r\nShares of <strong> <a href=\"https://laohu8.com/S/BLPH\">Bellerophon Therapeutics, Inc.</a> </strong> (NASDAQ:BLPH) got a boost, shooting 34% to $3.1694 after topline data from Phase 2 study (PULSE-PHPF-002) evaluating the acute hemodynamic benefit of INOpulse via right heart catheterization for pulmonary hypertension associated with sarcoidosis (PH-Sarc).</p>\n<p>\n<strong>X4 Pharmaceuticals, Inc. </strong> (NASDAQ:XFOR) shares were also up, gaining 27% to $3.0087.</p>\n<p>\n<em>Check out these big movers of the day</em></p>\n<p>\n<strong>Equities Trading DOWN</strong></p>\n<p><strong><a href=\"https://laohu8.com/S/BKSY\">BlackSky Technology Inc.</a> </strong> (NYSE:BKSY) shares tumbled 15% to $5.97.</p>\n<p>\r\nShares of <strong> <a href=\"https://laohu8.com/S/RIVN\">Rivian Automotive, Inc.</a> </strong> (NASDAQ:RIVN) were down 14% to $93.62 after the company reported Q3 earnings results and said it expects to be a few hundred vehicles short of its 2021 production target of 1,200 vehicles.</p>\n<p>\n<strong><a href=\"https://laohu8.com/S/TYRA\">Tyra Biosciences, Inc.</a> </strong> (NASDAQ:TYRA) was down, falling 12% to $12.15.</p>\n<p>\n<strong>Commodities</strong></p>\n<p>In commodity news, oil traded down 2% to $70.94, while gold traded up 0.6% to $1,808.70.</p>\n<p>\r\nSilver traded up 0.4% Friday to $22.58 while copper rose 0.4% to $4.3210.</p>\n<p>\n<strong>Euro zone</strong></p>\n<p>European shares were mostly lower today. The eurozone’s STOXX 600 declined 0.8%, the Spanish Ibex Index fell 0.8% and the German DAX 30 dropped 0.8%. Meanwhile, the London’s FTSE 100 gained 0.1%, French CAC 40 fell 0.9% and Italy’s FTSE MIB dipped 1.1%.</p>\n<p>The annual inflation rate in the Eurozone accelerated to 4.9% in November from 4.1% in the previous month, while construction output increased 4.4% year-over-year in October. Spain's trade deficit widened to EUR 3.4 billion in October from EUR 0.7 billion in the year-ago month.</p>\n<p>The Ifo Business Climate indicator for Germany dropped to 94.7 in December, while German producer prices surged 19.2% year-over-year in November, following an 18.4% growth in the prior month. Retail sales in the UK increased 1.4% in November. Passenger car registrations in the European Union dipped 20.5% year-over-year to 713,346 units in November.</p>\n<p>\n<strong>Economics</strong></p>\n<p>\r\nThe Baker Hughes North American rig count report for the latest week is scheduled for release at 1:00 p.m. ET.</p>\n<p>\r\nSan Francisco Federal Reserve President Mary Daly is set to speak at 1:00 p.m. ET.</p>\n<p>\r\nFederal Reserve Governor Christopher Waller will speak at 1:00 p.m. ET.</p>\n<p><em>Check out the full economic calendar here </em>\n</p>\n</body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DRI":"达登饭店","BKSY":"BlackSky Technology Inc.","IVT":"Inventrust Properties Corp.","GNFT":"Genfit S.A.","RIVN":"Rivian Automotive, Inc.","TYRA":"Tyra Biosciences, Inc.","XFOR":"X4制药"},"source_url":"https://www.benzinga.com/news/earnings/21/12/24671030/mid-morning-market-update-markets-open-lower-darden-restaurants-posts-upbeat-earnings","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192750849","content_text":"Following the market opening Friday, the Dow traded down 1.33% to 35,420.19 while the NASDAQ fell 0.61% to 15,082.68. The S&P also fell, dropping 1% to 4,622.16.\nThe U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 51,435,650 cases with around 824,520 deaths. India confirmed a total of at least 34,726,040 cases and 476,860 deaths, while Brazil reported over 22,204,940 COVID-19 cases with 617,520 deaths. In total, there were at least 273,330,020 cases of COVID-19 worldwide with more than 5,355,740 deaths.\n\nLeading and Lagging Sectors\n\r\nReal estate shares climbed 0.1% on Friday. Meanwhile, top gainers in the sector included  InvenTrust Properties Corp.  (NYSE:IVT), up 3% and  CatchMark Timber Trust, Inc.  (NYSE:CTT) up 3%.\n\r\nIn trading on Friday, financial shares fell 2.4%.\n\nTop Headline\n\nDarden Restaurants, Inc.  (NYSE:DRI) reported better-than-expected earnings for its second quarter and raised its FY22 sales guidance.\nDarden reported quarterly earnings of $1.48 per share, beating analysts’ estimates of $1.43 per share. The company’s quarterly sales came in at $2.27 billion, versus expectations of $2.23 billion.\nDarden raised its FY22 sales guidance from $9.4 billion-$9.6 billion to $9.55 billion-$9.7 billion. The company said Chairman and CEO Gene Lee will retire in May 2022 and named President and CFO Rick Cardenas as his replacement.\nEquities Trading UP\n\nGenfit SA  (NASDAQ:GNFT) shares shot up 46% to $4.83 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor.\n\r\nShares of  Bellerophon Therapeutics, Inc.  (NASDAQ:BLPH) got a boost, shooting 34% to $3.1694 after topline data from Phase 2 study (PULSE-PHPF-002) evaluating the acute hemodynamic benefit of INOpulse via right heart catheterization for pulmonary hypertension associated with sarcoidosis (PH-Sarc).\n\nX4 Pharmaceuticals, Inc.  (NASDAQ:XFOR) shares were also up, gaining 27% to $3.0087.\n\nCheck out these big movers of the day\n\nEquities Trading DOWN\nBlackSky Technology Inc.  (NYSE:BKSY) shares tumbled 15% to $5.97.\n\r\nShares of  Rivian Automotive, Inc.  (NASDAQ:RIVN) were down 14% to $93.62 after the company reported Q3 earnings results and said it expects to be a few hundred vehicles short of its 2021 production target of 1,200 vehicles.\n\nTyra Biosciences, Inc.  (NASDAQ:TYRA) was down, falling 12% to $12.15.\n\nCommodities\nIn commodity news, oil traded down 2% to $70.94, while gold traded up 0.6% to $1,808.70.\n\r\nSilver traded up 0.4% Friday to $22.58 while copper rose 0.4% to $4.3210.\n\nEuro zone\nEuropean shares were mostly lower today. The eurozone’s STOXX 600 declined 0.8%, the Spanish Ibex Index fell 0.8% and the German DAX 30 dropped 0.8%. Meanwhile, the London’s FTSE 100 gained 0.1%, French CAC 40 fell 0.9% and Italy’s FTSE MIB dipped 1.1%.\nThe annual inflation rate in the Eurozone accelerated to 4.9% in November from 4.1% in the previous month, while construction output increased 4.4% year-over-year in October. Spain's trade deficit widened to EUR 3.4 billion in October from EUR 0.7 billion in the year-ago month.\nThe Ifo Business Climate indicator for Germany dropped to 94.7 in December, while German producer prices surged 19.2% year-over-year in November, following an 18.4% growth in the prior month. Retail sales in the UK increased 1.4% in November. Passenger car registrations in the European Union dipped 20.5% year-over-year to 713,346 units in November.\n\nEconomics\n\r\nThe Baker Hughes North American rig count report for the latest week is scheduled for release at 1:00 p.m. ET.\n\r\nSan Francisco Federal Reserve President Mary Daly is set to speak at 1:00 p.m. ET.\n\r\nFederal Reserve Governor Christopher Waller will speak at 1:00 p.m. ET.\nCheck out the full economic calendar here","news_type":1,"symbols_score_info":{"BKSY":0.9,"BLPH":0.9,"CTT":0.9,"DRI":1,"GNFT":0.9,"IVT":0.9,"RIVN":0.9,"TYRA":0.9,"XFOR":0.9}},"isVote":1,"tweetType":1,"viewCount":1524,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699286765,"gmtCreate":1639811078351,"gmtModify":1639811078503,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"Like like like&nbsp;","listText":"Like like like&nbsp;","text":"Like like like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699286765","repostId":"2192971353","repostType":2,"repost":{"id":"2192971353","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639766659,"share":"https://ttm.financial/m/news/2192971353?lang=&edition=full","pubTime":"2021-12-18 02:44","market":"us","language":"en","title":"Palantir to localize UK data operations as privacy regulations tighten","url":"https://stock-news.laohu8.com/highlight/detail?id=2192971353","media":"Reuters","summary":"Dec 17 (Reuters) - Palantir Technologies Inc    said on Friday it plans to shift its entire UK data ","content":"<html><body><p>Dec 17 (Reuters) - Palantir Technologies Inc    said on Friday it plans to shift its entire UK data processing out of the United States, at a time when data privacy regulations are tightening across the globe.</p><p>   While Palantir already hosts all UK customer data within the country, handling of metadata is currently done in the United States.</p><p>   The company handles sensitive data for its clients in the UK including the National Health Service <a href=\"https://laohu8.com/S/NHS\">$(NHS)$</a>.</p><p>   Palantir plans to make the shift of data processing operations by the end of 2022, enabling customers in the UK and also the European Union <a href=\"https://laohu8.com/S/EU\">$(EU)$</a> to be less susceptible to potential data leaks or hacks.</p><p>   The move comes as regulations on how personal data should be stored, handled and processed are changing from region to region such as the General Data Protection Regulation (GDPR) in the EU.</p><p>As a result, there is an increasing shift towards localizing these processes to comply with tougher regulatory requirements, all amid tense relations between the United States and China.</p><p>   Palantir, which has garnered its reputation from its work with the U.S. Defense Department and intelligence agencies like the U.S. Central Intelligence Agency, has said that it only works with the United States and its allies.</p><p>   The company, backed by tech billionaire Peter Thiel, said the shift will allow the UK to be \"fully autonomous as regulations change and geopolitical threats around the world increase.\"</p><p>   The move, which will be a multi-million pound investment for the company, will create 250 new jobs at its London headquarters, the U.S.-based software-as-a-service company said.</p><p> (Reporting by Chavi Mehta in Bengaluru; Editing by Maju Samuel)</p><p>((Chavi.Mehta@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir to localize UK data operations as privacy regulations tighten</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir to localize UK data operations as privacy regulations tighten\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-18 02:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Dec 17 (Reuters) - Palantir Technologies Inc    said on Friday it plans to shift its entire UK data processing out of the United States, at a time when data privacy regulations are tightening across the globe.</p><p>   While Palantir already hosts all UK customer data within the country, handling of metadata is currently done in the United States.</p><p>   The company handles sensitive data for its clients in the UK including the National Health Service <a href=\"https://laohu8.com/S/NHS\">$(NHS)$</a>.</p><p>   Palantir plans to make the shift of data processing operations by the end of 2022, enabling customers in the UK and also the European Union <a href=\"https://laohu8.com/S/EU\">$(EU)$</a> to be less susceptible to potential data leaks or hacks.</p><p>   The move comes as regulations on how personal data should be stored, handled and processed are changing from region to region such as the General Data Protection Regulation (GDPR) in the EU.</p><p>As a result, there is an increasing shift towards localizing these processes to comply with tougher regulatory requirements, all amid tense relations between the United States and China.</p><p>   Palantir, which has garnered its reputation from its work with the U.S. Defense Department and intelligence agencies like the U.S. Central Intelligence Agency, has said that it only works with the United States and its allies.</p><p>   The company, backed by tech billionaire Peter Thiel, said the shift will allow the UK to be \"fully autonomous as regulations change and geopolitical threats around the world increase.\"</p><p>   The move, which will be a multi-million pound investment for the company, will create 250 new jobs at its London headquarters, the U.S.-based software-as-a-service company said.</p><p> (Reporting by Chavi Mehta in Bengaluru; Editing by Maju Samuel)</p><p>((Chavi.Mehta@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc.","BK4547":"WSB热门概念","EU":"ENCORE ENERGY CORP","BK4023":"应用软件","NHS":"纽伯格伯曼高地策略基金","BK4543":"AI"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192971353","content_text":"Dec 17 (Reuters) - Palantir Technologies Inc    said on Friday it plans to shift its entire UK data processing out of the United States, at a time when data privacy regulations are tightening across the globe.   While Palantir already hosts all UK customer data within the country, handling of metadata is currently done in the United States.   The company handles sensitive data for its clients in the UK including the National Health Service $(NHS)$.   Palantir plans to make the shift of data processing operations by the end of 2022, enabling customers in the UK and also the European Union $(EU)$ to be less susceptible to potential data leaks or hacks.   The move comes as regulations on how personal data should be stored, handled and processed are changing from region to region such as the General Data Protection Regulation (GDPR) in the EU.As a result, there is an increasing shift towards localizing these processes to comply with tougher regulatory requirements, all amid tense relations between the United States and China.   Palantir, which has garnered its reputation from its work with the U.S. Defense Department and intelligence agencies like the U.S. Central Intelligence Agency, has said that it only works with the United States and its allies.   The company, backed by tech billionaire Peter Thiel, said the shift will allow the UK to be \"fully autonomous as regulations change and geopolitical threats around the world increase.\"   The move, which will be a multi-million pound investment for the company, will create 250 new jobs at its London headquarters, the U.S.-based software-as-a-service company said. (Reporting by Chavi Mehta in Bengaluru; Editing by Maju Samuel)((Chavi.Mehta@thomsonreuters.com;))","news_type":1,"symbols_score_info":{"EU":1,"NHS":1,"PLTR":0.9}},"isVote":1,"tweetType":1,"viewCount":1431,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699286594,"gmtCreate":1639811039517,"gmtModify":1639811039631,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"Like like like&nbsp;","listText":"Like like like&nbsp;","text":"Like like like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699286594","repostId":"2192677978","repostType":2,"repost":{"id":"2192677978","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639749246,"share":"https://ttm.financial/m/news/2192677978?lang=&edition=full","pubTime":"2021-12-17 21:54","market":"us","language":"en","title":"The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx","url":"https://stock-news.laohu8.com/highlight/detail?id=2192677978","media":"Benzinga","summary":"Here&#39;s a roundup of top developments in the biotech space over the last 24 hours.","content":"<html><body><p>Here's a roundup of top developments in the biotech space over the last 24 hours.</p>\n<h3>Stocks In Focus</h3>\n<h3>Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral COVID-19 Antiviral Treatment</h3>\n<p><strong>Merck &amp; Co., Inc. </strong>(NYSE:MRK) and Ridgeback Biotherapeutics announced the New England Journal of Medicines has published findings from the Phase 3 MOVe-OUT trial evaluating molnupiravir,  in non-hospitalized high risk adults with mild to moderate COVID-19, showing early treatment with molnupiravir significantly reduced the risk of hospitalization or death in high risk, unvaccinated adults with COVID-19.</p>\n<p>Separately, Merck said the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Keytruda as monotherapy for the adjuvant treatment of adults with renal cell carcinoma at increased risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions.</p>\n<p>Merck shares were rising 1.17% to $76.80 in premarket trading.</p>\n<h3>Lyell Announces FDA Clearance For Initiating Phase 1 Study Of Solid Tumor Investigational Therapy</h3>\n<p><strong><a href=\"https://laohu8.com/S/LYEL\">Lyell Immunopharma, Inc.</a> </strong>(NASDAQ:LYEL) announced the U.S. Food and Drug Administration has cleared its investigational new drug application to initiate a Phase 1 clinical trial for LYL797, its first therapeutic candidate incorporating T-cell reprogramming technologies for the treatment of solid tumors.</p>\n<p>Lyell said it expects to begin screening patients with relapsed/refractory triple-negative breast cancer, who have failed at least two lines of therapy by the end of the first quarter for the Phase 1 dose escalation phase of the trial and plans to expand the trial to include patients with non-small cell lung cancer when a recommended dose is determined.</p>\n<p>The stock was up 4.47% at $9.35 in premarket trading.</p>\n<p><em>Click  here  to access Benzinga's FDA Calendar</em></p>\n<h3>Allovir's Chief Medical Officer To Step Down</h3>\n<p><strong>AlloVir </strong>(NASDAQ:ALVR) announced that Augustin Melian, its chief medical officer, has decided to leave the company at the end of this year. Melian has agreed to work with AlloVir in an advisory capacity to ensure a smooth transition.</p>\n<p>Richard Riese, Senior Vice President, Clinical Research, will continue to lead the company's clinical development programs, including oversight of the Phase 3 studies for posoleucel, the company said.</p>\n<h3>Pfizer, BioNTech File For Expanding Approval Of COVID-19 Vaccine For Adolescents</h3>\n<p><strong>Pfizer, Inc. </strong>(NYSE:PFE) and<strong><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> </strong>(NASDAQ:BNTX) announced they have submitted a supplemental biologics license application to the FDA for expanding the approval of Comirnaty  to include individuals ages 12 through 15 years.</p>\n<h3>ObsEva Says EMA Committee Recommends Approval Of Uterine Fibroid Treatment</h3>\n<p><strong>ObsEva SA </strong>(NASDAQ:OBSV) announced EMA's CHMP adopted a positive opinion recommending approval of linzagolix, an oral GnRH antagonist for the management of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.</p>\n<p>The shares were up 6.39% to $2.33 in premarket trading.</p>\n<h3>Genfit Our-licenses Liver Disease Drug To Ispen, Sells Equity Stake to The French Biopharma</h3>\n<p><strong>GENFIT </strong>(NASDAQ:GNFT) and Ispen said they have entered into a long-term strategic partnership for a global collaboration between the two companies. The agreement gives Ipsen exclusive worldwide license to develop, manufacture and commercialize Genfit's investigational treatment elafibranor, for people living with primary biliary cholangitis.</p>\n<p>The partnership also gives Ipsen access to future clinical programs led by Genfit and combines Genfit's scientific expertise and proprietary technologies in liver disease with Ipsen's development and commercialization capabilities.</p>\n<p>Ipsen will also purchase newly issued Genfit equity representing 8% post-issuance through a 28-million-euro ($31.73 million) investment.</p>\n<p>Separately, Genfit announced the acquisition of exclusive rights from Genoscience Pharma to develop and commercialize the investigational treatment GNS561 in cholangiocarcinoma in the U.S. Canada and Europe, including the U.K. and Switzerland.</p>\n<p>Genfit shares were rising 42.77% to $4.74 in premarket trading.</p>\n<h3>Biogen's Aducanumab Receives Negative Opinion From EMA Committee</h3>\n<p><strong>Biogen, Inc. </strong>(NASDAQ:BIIB) and <strong>Eisai Co., Ltd. </strong>(PNK: ESALY) announced that EMA's CHMP has adopted a negative opinion on the marketing authorization application for aducanumab for the treatment of the early stages of Alzheimer's disease known as mild cognitive impairment due to Alzheimer's disease and mild Alzheimer's disease dementia. This decision is aligned to the negative trend vote of the committee in November 2021. Biogen said it will seek a re-examination of the opinion by the CHMP.</p>\n<p>The shares were down 1.92% to $230.99 in premarket trading.</p>\n<h3>CASI To Buy Back $10M Worth Of Shares</h3>\n<p><strong>CASI Pharmaceuticals, Inc. </strong>(NASDAQ:CASI) announced that its board of directors approved a stock repurchase program for the repurchase of up to $10 million of the common stock through open market purchases.</p>\n<p>The stock was up 3.25% to 79.50 in premarket trading.</p>\n<h3>Navidea Announces Commencement Of Late-Stage Study Of Imaging Agent to Predict Response In Rheumatoid Arthritis Patients</h3>\n<p><strong><a href=\"https://laohu8.com/S/NAVB\">Navidea Biopharmaceuticals</a>, Inc. </strong>(NYSE:NAVB) announced the launch of the NAV3-33 Phase 3 clinical trial, evaluating Tc99m tilmanocept imaging for the early prediction of anti-TNFα therapy response in patients with moderate to severe active rheumatoid arthritis.</p>\n<p>The stock was up 2.48% to $1.24 in premarket trading.</p>\n<p><em>Related Link:  Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates</em></p>\n<h3>On The Radar</h3>\n<h3>PDUFA Dates</h3>\n<p>The FDA is expected to rule on <strong>Intra-Cellular Therapies, Inc.'s </strong>(NASDAQ:ITCI) Caplyta for the expanded indication of bipolar disorder,</p>\n<p>The regulator is also due to give its verdict on <strong>argenx SE's </strong>(NASDAQ:ARGX) biologic license application for efgartigimod for the treatment of generalized myasthenia gravis.</p>\n<h3>Earnings</h3>\n<p><strong>Sonnet BioTherapeutics Holdings, Inc. </strong>(NASDAQ:SONN) (before the market open)</p>\n</body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-17 21:54</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Here's a roundup of top developments in the biotech space over the last 24 hours.</p>\n<h3>Stocks In Focus</h3>\n<h3>Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral COVID-19 Antiviral Treatment</h3>\n<p><strong>Merck &amp; Co., Inc. </strong>(NYSE:MRK) and Ridgeback Biotherapeutics announced the New England Journal of Medicines has published findings from the Phase 3 MOVe-OUT trial evaluating molnupiravir,  in non-hospitalized high risk adults with mild to moderate COVID-19, showing early treatment with molnupiravir significantly reduced the risk of hospitalization or death in high risk, unvaccinated adults with COVID-19.</p>\n<p>Separately, Merck said the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Keytruda as monotherapy for the adjuvant treatment of adults with renal cell carcinoma at increased risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions.</p>\n<p>Merck shares were rising 1.17% to $76.80 in premarket trading.</p>\n<h3>Lyell Announces FDA Clearance For Initiating Phase 1 Study Of Solid Tumor Investigational Therapy</h3>\n<p><strong><a href=\"https://laohu8.com/S/LYEL\">Lyell Immunopharma, Inc.</a> </strong>(NASDAQ:LYEL) announced the U.S. Food and Drug Administration has cleared its investigational new drug application to initiate a Phase 1 clinical trial for LYL797, its first therapeutic candidate incorporating T-cell reprogramming technologies for the treatment of solid tumors.</p>\n<p>Lyell said it expects to begin screening patients with relapsed/refractory triple-negative breast cancer, who have failed at least two lines of therapy by the end of the first quarter for the Phase 1 dose escalation phase of the trial and plans to expand the trial to include patients with non-small cell lung cancer when a recommended dose is determined.</p>\n<p>The stock was up 4.47% at $9.35 in premarket trading.</p>\n<p><em>Click  here  to access Benzinga's FDA Calendar</em></p>\n<h3>Allovir's Chief Medical Officer To Step Down</h3>\n<p><strong>AlloVir </strong>(NASDAQ:ALVR) announced that Augustin Melian, its chief medical officer, has decided to leave the company at the end of this year. Melian has agreed to work with AlloVir in an advisory capacity to ensure a smooth transition.</p>\n<p>Richard Riese, Senior Vice President, Clinical Research, will continue to lead the company's clinical development programs, including oversight of the Phase 3 studies for posoleucel, the company said.</p>\n<h3>Pfizer, BioNTech File For Expanding Approval Of COVID-19 Vaccine For Adolescents</h3>\n<p><strong>Pfizer, Inc. </strong>(NYSE:PFE) and<strong><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> </strong>(NASDAQ:BNTX) announced they have submitted a supplemental biologics license application to the FDA for expanding the approval of Comirnaty  to include individuals ages 12 through 15 years.</p>\n<h3>ObsEva Says EMA Committee Recommends Approval Of Uterine Fibroid Treatment</h3>\n<p><strong>ObsEva SA </strong>(NASDAQ:OBSV) announced EMA's CHMP adopted a positive opinion recommending approval of linzagolix, an oral GnRH antagonist for the management of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.</p>\n<p>The shares were up 6.39% to $2.33 in premarket trading.</p>\n<h3>Genfit Our-licenses Liver Disease Drug To Ispen, Sells Equity Stake to The French Biopharma</h3>\n<p><strong>GENFIT </strong>(NASDAQ:GNFT) and Ispen said they have entered into a long-term strategic partnership for a global collaboration between the two companies. The agreement gives Ipsen exclusive worldwide license to develop, manufacture and commercialize Genfit's investigational treatment elafibranor, for people living with primary biliary cholangitis.</p>\n<p>The partnership also gives Ipsen access to future clinical programs led by Genfit and combines Genfit's scientific expertise and proprietary technologies in liver disease with Ipsen's development and commercialization capabilities.</p>\n<p>Ipsen will also purchase newly issued Genfit equity representing 8% post-issuance through a 28-million-euro ($31.73 million) investment.</p>\n<p>Separately, Genfit announced the acquisition of exclusive rights from Genoscience Pharma to develop and commercialize the investigational treatment GNS561 in cholangiocarcinoma in the U.S. Canada and Europe, including the U.K. and Switzerland.</p>\n<p>Genfit shares were rising 42.77% to $4.74 in premarket trading.</p>\n<h3>Biogen's Aducanumab Receives Negative Opinion From EMA Committee</h3>\n<p><strong>Biogen, Inc. </strong>(NASDAQ:BIIB) and <strong>Eisai Co., Ltd. </strong>(PNK: ESALY) announced that EMA's CHMP has adopted a negative opinion on the marketing authorization application for aducanumab for the treatment of the early stages of Alzheimer's disease known as mild cognitive impairment due to Alzheimer's disease and mild Alzheimer's disease dementia. This decision is aligned to the negative trend vote of the committee in November 2021. Biogen said it will seek a re-examination of the opinion by the CHMP.</p>\n<p>The shares were down 1.92% to $230.99 in premarket trading.</p>\n<h3>CASI To Buy Back $10M Worth Of Shares</h3>\n<p><strong>CASI Pharmaceuticals, Inc. </strong>(NASDAQ:CASI) announced that its board of directors approved a stock repurchase program for the repurchase of up to $10 million of the common stock through open market purchases.</p>\n<p>The stock was up 3.25% to 79.50 in premarket trading.</p>\n<h3>Navidea Announces Commencement Of Late-Stage Study Of Imaging Agent to Predict Response In Rheumatoid Arthritis Patients</h3>\n<p><strong><a href=\"https://laohu8.com/S/NAVB\">Navidea Biopharmaceuticals</a>, Inc. </strong>(NYSE:NAVB) announced the launch of the NAV3-33 Phase 3 clinical trial, evaluating Tc99m tilmanocept imaging for the early prediction of anti-TNFα therapy response in patients with moderate to severe active rheumatoid arthritis.</p>\n<p>The stock was up 2.48% to $1.24 in premarket trading.</p>\n<p><em>Related Link:  Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates</em></p>\n<h3>On The Radar</h3>\n<h3>PDUFA Dates</h3>\n<p>The FDA is expected to rule on <strong>Intra-Cellular Therapies, Inc.'s </strong>(NASDAQ:ITCI) Caplyta for the expanded indication of bipolar disorder,</p>\n<p>The regulator is also due to give its verdict on <strong>argenx SE's </strong>(NASDAQ:ARGX) biologic license application for efgartigimod for the treatment of generalized myasthenia gravis.</p>\n<h3>Earnings</h3>\n<p><strong>Sonnet BioTherapeutics Holdings, Inc. </strong>(NASDAQ:SONN) (before the market open)</p>\n</body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CASI":"凯信远达","BK4139":"生物科技","MRK":"默沙东","GNFTF":"Genfit","NAVB":"Navidea生物制药","BNTX":"BioNTech SE","ARGX":"Argenx SE","IBB":"生物科技指数ETF-iShares Nasdaq","SONN":"Sonnet BioTherapeutics Holdings, Inc.","BIIB":"渤健公司","ITCI":"Intra-Cellular Therapies Inc.","PFE":"辉瑞","LYEL":"Lyell Immunopharma, Inc.","GNFT":"Genfit S.A."},"source_url":"https://www.benzinga.com/general/biotech/21/12/24666393/the-daily-biotech-pulse-genfit-spikes-on-liver-disease-drug-licensing-deal-lyell-gets-nod-for-sol","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192677978","content_text":"Here's a roundup of top developments in the biotech space over the last 24 hours.\nStocks In Focus\nMerck Announces Publication Of Positive Data From Late-Stage Study Of Oral COVID-19 Antiviral Treatment\nMerck & Co., Inc. (NYSE:MRK) and Ridgeback Biotherapeutics announced the New England Journal of Medicines has published findings from the Phase 3 MOVe-OUT trial evaluating molnupiravir,  in non-hospitalized high risk adults with mild to moderate COVID-19, showing early treatment with molnupiravir significantly reduced the risk of hospitalization or death in high risk, unvaccinated adults with COVID-19.\nSeparately, Merck said the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Keytruda as monotherapy for the adjuvant treatment of adults with renal cell carcinoma at increased risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions.\nMerck shares were rising 1.17% to $76.80 in premarket trading.\nLyell Announces FDA Clearance For Initiating Phase 1 Study Of Solid Tumor Investigational Therapy\nLyell Immunopharma, Inc. (NASDAQ:LYEL) announced the U.S. Food and Drug Administration has cleared its investigational new drug application to initiate a Phase 1 clinical trial for LYL797, its first therapeutic candidate incorporating T-cell reprogramming technologies for the treatment of solid tumors.\nLyell said it expects to begin screening patients with relapsed/refractory triple-negative breast cancer, who have failed at least two lines of therapy by the end of the first quarter for the Phase 1 dose escalation phase of the trial and plans to expand the trial to include patients with non-small cell lung cancer when a recommended dose is determined.\nThe stock was up 4.47% at $9.35 in premarket trading.\nClick  here  to access Benzinga's FDA Calendar\nAllovir's Chief Medical Officer To Step Down\nAlloVir (NASDAQ:ALVR) announced that Augustin Melian, its chief medical officer, has decided to leave the company at the end of this year. Melian has agreed to work with AlloVir in an advisory capacity to ensure a smooth transition.\nRichard Riese, Senior Vice President, Clinical Research, will continue to lead the company's clinical development programs, including oversight of the Phase 3 studies for posoleucel, the company said.\nPfizer, BioNTech File For Expanding Approval Of COVID-19 Vaccine For Adolescents\nPfizer, Inc. (NYSE:PFE) andBioNTech SE (NASDAQ:BNTX) announced they have submitted a supplemental biologics license application to the FDA for expanding the approval of Comirnaty  to include individuals ages 12 through 15 years.\nObsEva Says EMA Committee Recommends Approval Of Uterine Fibroid Treatment\nObsEva SA (NASDAQ:OBSV) announced EMA's CHMP adopted a positive opinion recommending approval of linzagolix, an oral GnRH antagonist for the management of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.\nThe shares were up 6.39% to $2.33 in premarket trading.\nGenfit Our-licenses Liver Disease Drug To Ispen, Sells Equity Stake to The French Biopharma\nGENFIT (NASDAQ:GNFT) and Ispen said they have entered into a long-term strategic partnership for a global collaboration between the two companies. The agreement gives Ipsen exclusive worldwide license to develop, manufacture and commercialize Genfit's investigational treatment elafibranor, for people living with primary biliary cholangitis.\nThe partnership also gives Ipsen access to future clinical programs led by Genfit and combines Genfit's scientific expertise and proprietary technologies in liver disease with Ipsen's development and commercialization capabilities.\nIpsen will also purchase newly issued Genfit equity representing 8% post-issuance through a 28-million-euro ($31.73 million) investment.\nSeparately, Genfit announced the acquisition of exclusive rights from Genoscience Pharma to develop and commercialize the investigational treatment GNS561 in cholangiocarcinoma in the U.S. Canada and Europe, including the U.K. and Switzerland.\nGenfit shares were rising 42.77% to $4.74 in premarket trading.\nBiogen's Aducanumab Receives Negative Opinion From EMA Committee\nBiogen, Inc. (NASDAQ:BIIB) and Eisai Co., Ltd. (PNK: ESALY) announced that EMA's CHMP has adopted a negative opinion on the marketing authorization application for aducanumab for the treatment of the early stages of Alzheimer's disease known as mild cognitive impairment due to Alzheimer's disease and mild Alzheimer's disease dementia. This decision is aligned to the negative trend vote of the committee in November 2021. Biogen said it will seek a re-examination of the opinion by the CHMP.\nThe shares were down 1.92% to $230.99 in premarket trading.\nCASI To Buy Back $10M Worth Of Shares\nCASI Pharmaceuticals, Inc. (NASDAQ:CASI) announced that its board of directors approved a stock repurchase program for the repurchase of up to $10 million of the common stock through open market purchases.\nThe stock was up 3.25% to 79.50 in premarket trading.\nNavidea Announces Commencement Of Late-Stage Study Of Imaging Agent to Predict Response In Rheumatoid Arthritis Patients\nNavidea Biopharmaceuticals, Inc. (NYSE:NAVB) announced the launch of the NAV3-33 Phase 3 clinical trial, evaluating Tc99m tilmanocept imaging for the early prediction of anti-TNFα therapy response in patients with moderate to severe active rheumatoid arthritis.\nThe stock was up 2.48% to $1.24 in premarket trading.\nRelated Link:  Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates\nOn The Radar\nPDUFA Dates\nThe FDA is expected to rule on Intra-Cellular Therapies, Inc.'s (NASDAQ:ITCI) Caplyta for the expanded indication of bipolar disorder,\nThe regulator is also due to give its verdict on argenx SE's (NASDAQ:ARGX) biologic license application for efgartigimod for the treatment of generalized myasthenia gravis.\nEarnings\nSonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (before the market open)","news_type":1,"symbols_score_info":{"ALVR":0.9,"ARGX":0.9,"BIIB":0.9,"BNTX":0.9,"CASI":0.9,"GNFT":0.9,"GNFTF":1,"IBB":0.9,"ITCI":0.9,"LYEL":0.9,"MRK":0.9,"NAVB":0.9,"OBSV":0.9,"PFE":0.9,"SONN":0.9}},"isVote":1,"tweetType":1,"viewCount":1820,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607002231,"gmtCreate":1639452081597,"gmtModify":1639452224578,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"Up up up","listText":"Up up up","text":"Up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607002231","repostId":"1180743412","repostType":2,"repost":{"id":"1180743412","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639408228,"share":"https://ttm.financial/m/news/1180743412?lang=&edition=full","pubTime":"2021-12-13 23:10","market":"us","language":"en","title":"Trump stocks slid sharply in morning trading ,with DWAC and Phunware falling over 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1180743412","media":"Tiger Newspress","summary":"Trump stocks slid sharply in morning trading ,with DWAC and Phunware falling over 5%.","content":"<p>Trump stocks slid sharply in morning trading ,with DWAC and Phunware falling over 5%.<img src=\"https://static.tigerbbs.com/8c494e3841010c65a07f05aaacf0d443\" tg-width=\"772\" tg-height=\"573\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Trump stocks slid sharply in morning trading ,with DWAC and Phunware falling over 5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTrump stocks slid sharply in morning trading ,with DWAC and Phunware falling over 5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 23:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Trump stocks slid sharply in morning trading ,with DWAC and Phunware falling over 5%.<img src=\"https://static.tigerbbs.com/8c494e3841010c65a07f05aaacf0d443\" tg-width=\"772\" tg-height=\"573\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PHUN":"Phunware, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180743412","content_text":"Trump stocks slid sharply in morning trading ,with DWAC and Phunware falling over 5%.","news_type":1,"symbols_score_info":{"DWAC":0.9,"PHUN":0.9}},"isVote":1,"tweetType":1,"viewCount":1348,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607006944,"gmtCreate":1639451945831,"gmtModify":1639452178472,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"Up up up&nbsp;","listText":"Up up up&nbsp;","text":"Up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607006944","repostId":"1198823118","repostType":2,"isVote":1,"tweetType":1,"viewCount":1659,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608993023,"gmtCreate":1638590441966,"gmtModify":1638590442035,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"Like like like&nbsp;","listText":"Like like like&nbsp;","text":"Like like like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608993023","repostId":"1189400421","repostType":2,"repost":{"id":"1189400421","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638260750,"share":"https://ttm.financial/m/news/1189400421?lang=&edition=full","pubTime":"2021-11-30 16:25","market":"us","language":"en","title":"Tiger Brokers reported the third quarter ended September 30, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=1189400421","media":"Tiger Newspress","summary":"Before the market on November 30, US Eastern Time, Tiger International, a world-renowned technology brokerage firm,$Tiger Brokers$Announce the unaudited financial report for the third quarter ended September 30, 2021. According to the financial report,The company achieved a total revenue of 60.78 million US dollars in the third quarter, a year-on-year increase of 59.6%; Non-GAAP net profit is USD 5.26 million.Wu Tianhua, founder and CEO of Tiger International, said: \"In the third quarter, Tiger ","content":"<p>Before the market on November 30, US Eastern Time, Tiger International, a world-renowned technology brokerage firm,<a href=\"https://laohu8.com/S/TIGR\">Tiger Brokers</a>Announce the unaudited financial report for the third quarter ended September 30, 2021. According to the financial report,<b>The company achieved a total revenue of 60.78 million US dollars in the third quarter, a year-on-year increase of 59.6%; Non-GAAP net profit is USD 5.26 million</b>.</p><p>During the quarter, Tiger International continued to actively promote its internationalization strategy. By the end of the third quarter,<b>Tiger International's global account opening customers increased by 118,000 to 1.767 million, nearly twice that at the end of the same period last year; The number of global cash-in customers increased to 612,000, nearly three times that at the end of the same period last year, and over 80% of the newly added cash-in customers in a single quarter came from overseas. It is worth mentioning that Tiger International has accumulated 353,000 new customers in the first three quarters, and completed the annual deposit guideline of 350,000 ahead of schedule.</b></p><p>Wu Tianhua, founder and CEO of Tiger International, said: \"In the third quarter, Tiger International made steady progress towards the goal of 'World-class Technology Broker'. Recently,<b>The company has successfully obtained Class 1 and Class 2 licenses in Hong Kong, and can enter the Hong Kong market to provide securities brokerage, futures brokerage and other services for local customers</b>. At the same time, we have continuously consolidated our leading edge in Singapore, taking the lead in winning four qualification certifications, such as clearing member and securities trading member, of SGX, and accelerating our integration into local financial infrastructure. Looking ahead, we will continue to firmly invest in technological innovation, provide safe, inclusive and convenient products and services for global investors with science and technology on the basis of compliance and self-discipline, and demonstrate China's scientific and technological innovation strength. \"</p><p><img src=\"https://static.tigerbbs.com/0b1a1c012f690fad69e97980912a9aaf\" tg-width=\"1080\" tg-height=\"19929\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tiger Brokers reported the third quarter ended September 30, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTiger Brokers reported the third quarter ended September 30, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-30 16:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Before the market on November 30, US Eastern Time, Tiger International, a world-renowned technology brokerage firm,<a href=\"https://laohu8.com/S/TIGR\">Tiger Brokers</a>Announce the unaudited financial report for the third quarter ended September 30, 2021. According to the financial report,<b>The company achieved a total revenue of 60.78 million US dollars in the third quarter, a year-on-year increase of 59.6%; Non-GAAP net profit is USD 5.26 million</b>.</p><p>During the quarter, Tiger International continued to actively promote its internationalization strategy. By the end of the third quarter,<b>Tiger International's global account opening customers increased by 118,000 to 1.767 million, nearly twice that at the end of the same period last year; The number of global cash-in customers increased to 612,000, nearly three times that at the end of the same period last year, and over 80% of the newly added cash-in customers in a single quarter came from overseas. It is worth mentioning that Tiger International has accumulated 353,000 new customers in the first three quarters, and completed the annual deposit guideline of 350,000 ahead of schedule.</b></p><p>Wu Tianhua, founder and CEO of Tiger International, said: \"In the third quarter, Tiger International made steady progress towards the goal of 'World-class Technology Broker'. Recently,<b>The company has successfully obtained Class 1 and Class 2 licenses in Hong Kong, and can enter the Hong Kong market to provide securities brokerage, futures brokerage and other services for local customers</b>. At the same time, we have continuously consolidated our leading edge in Singapore, taking the lead in winning four qualification certifications, such as clearing member and securities trading member, of SGX, and accelerating our integration into local financial infrastructure. Looking ahead, we will continue to firmly invest in technological innovation, provide safe, inclusive and convenient products and services for global investors with science and technology on the basis of compliance and self-discipline, and demonstrate China's scientific and technological innovation strength. \"</p><p><img src=\"https://static.tigerbbs.com/0b1a1c012f690fad69e97980912a9aaf\" tg-width=\"1080\" tg-height=\"19929\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TIGR":"老虎证券"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189400421","content_text":"Before the market on November 30, US Eastern Time, Tiger International, a world-renowned technology brokerage firm,Tiger BrokersAnnounce the unaudited financial report for the third quarter ended September 30, 2021. According to the financial report,The company achieved a total revenue of 60.78 million US dollars in the third quarter, a year-on-year increase of 59.6%; Non-GAAP net profit is USD 5.26 million.During the quarter, Tiger International continued to actively promote its internationalization strategy. By the end of the third quarter,Tiger International's global account opening customers increased by 118,000 to 1.767 million, nearly twice that at the end of the same period last year; The number of global cash-in customers increased to 612,000, nearly three times that at the end of the same period last year, and over 80% of the newly added cash-in customers in a single quarter came from overseas. It is worth mentioning that Tiger International has accumulated 353,000 new customers in the first three quarters, and completed the annual deposit guideline of 350,000 ahead of schedule.Wu Tianhua, founder and CEO of Tiger International, said: \"In the third quarter, Tiger International made steady progress towards the goal of 'World-class Technology Broker'. Recently,The company has successfully obtained Class 1 and Class 2 licenses in Hong Kong, and can enter the Hong Kong market to provide securities brokerage, futures brokerage and other services for local customers. At the same time, we have continuously consolidated our leading edge in Singapore, taking the lead in winning four qualification certifications, such as clearing member and securities trading member, of SGX, and accelerating our integration into local financial infrastructure. Looking ahead, we will continue to firmly invest in technological innovation, provide safe, inclusive and convenient products and services for global investors with science and technology on the basis of compliance and self-discipline, and demonstrate China's scientific and technological innovation strength. \"","news_type":1,"symbols_score_info":{"TIGR":0.9}},"isVote":1,"tweetType":1,"viewCount":1741,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608904638,"gmtCreate":1638589830621,"gmtModify":1638589830738,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"Like like like&nbsp;","listText":"Like like like&nbsp;","text":"Like like like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608904638","repostId":"1119529609","repostType":2,"isVote":1,"tweetType":1,"viewCount":642,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877126461,"gmtCreate":1637900657374,"gmtModify":1637900657442,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"Up up up up&nbsp;","listText":"Up up up up&nbsp;","text":"Up up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877126461","repostId":"1154066141","repostType":2,"isVote":1,"tweetType":1,"viewCount":404,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877126018,"gmtCreate":1637900602233,"gmtModify":1637900602339,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877126018","repostId":"1143359507","repostType":2,"isVote":1,"tweetType":1,"viewCount":461,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877128528,"gmtCreate":1637900546463,"gmtModify":1637900546562,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"Like like like&nbsp;","listText":"Like like like&nbsp;","text":"Like like like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877128528","repostId":"2185389143","repostType":2,"repost":{"id":"2185389143","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1637686091,"share":"https://ttm.financial/m/news/2185389143?lang=&edition=full","pubTime":"2021-11-24 00:48","market":"us","language":"en","title":"FOCUS-U.S. tech execs hone approach to counter unions amid growing worker interest","url":"https://stock-news.laohu8.com/highlight/detail?id=2185389143","media":"Reuters","summary":"By Julia Love   SAN FRANCISCO, Nov 23 (Reuters) - In June, managers at location data startup Mapbox ","content":"<html><body><p>By Julia Love</p><p>   SAN FRANCISCO, Nov 23 (Reuters) - In June, managers at location data startup Mapbox came to employees with alarming news: The company had lost a $150 million investment, and worker organizing was to blame.</p><p>   Prior to the all-hands meeting over <a href=\"https://laohu8.com/S/ZM\">Zoom</a>, roughly two-thirds of the SoftBank-backed startup’s workers had signed cards indicating their desire to unionize, part of a wave of organizing in Silicon Valley. </p><p>   But after Mapbox management disclosed the botched investment – and said they worried funding trouble would persist if workers formed a union – the tide turned, <a href=\"https://laohu8.com/S/AONE.U\">one</a> current and one former employee said. Workers at Mapbox, which was valued at more than $1 billion in its most recent private funding round and has engaged with so-called blank check companies about going public, voted against unionization in August.</p><p>   Mapbox's response offers a window into how tech companies are pushing back as unions seek to bring workers into the fold. </p><p>   In recent years, the Communications Workers of America and the Office and Professional Employees International Union have launched campaigns in Silicon Valley, organizing workers at startups such as Kickstarter and Glitch. The CWA also formed the Alphabet Workers Union, a so-called minority union that does not have collective bargaining rights.</p><p>   As unions continue engaging with workers, a playbook among tech companies is emerging, according to interviews with tech workers and union organizers: Warn employees about the impact a union would have on the startup’s prospects and, in particular, its ability to raise funds. Remind workers of their privilege to cast doubt on why they need a union. And hire law firms and consultants to help drive the point home.  </p><p>   “Tech firms are willing to do whatever is necessary to keep unions out,” said John Logan, a labor professor at San Francisco State University. “They might think unions are fine for food-processing workers or for miners, but not in the tech sector.” </p><p>   SHIFTING POWER DYNAMIC </p><p>   The unions’ pushes are at an early stage, and it remains to be seen whether they will catch on widely. But the growing receptiveness in a sector long regarded as indifferent to organized labor speaks to a broader renegotiation of power that is playing out between tech companies and their employees, interviews with workers suggest.   </p><p>   For many tech workers, the promise of a generous payday is no longer enough. They also want sound working conditions and assurances that the products they are building will not harm society, tech employees and organizers say.</p><p>   Yet workers at high-risk, high-reward startups are loath to jeopardize the value of their stock options, or put their jobs at risk. That is why warnings about funding can be so effective, said Wes McEnany, a senior CWA campaign lead. </p><p>   In addition to Mapbox, management also said unionization could imperil future funding at Kickstarter and Glitch, according to former employees. Medium Chief Executive Ev Williams told workers that investors might shy away if the union prevailed, McEnany said. </p><p>   \"After considering the benefits and costs, our employees voted overwhelmingly against forming a union,\" Mapbox said in a statement. \"It was their decision to make, and they made it unambiguously. We’re now focused on growing our business and supporting our customers.\" </p><p>   Kickstarter and Glitch declined to comment. Williams did not respond.</p><p>   Under U.S. law, companies may not threaten workers that they will lose their jobs if they unionize, but they can predict adverse consequences, said Gordon Lafer of the University of Oregon's Labor Education and Research Center.  </p><p>   A VERY SCARY NUMBER</p><p>   Some investors and financial advisers interviewed by Reuters said they view unions at startups as a drawback because they make it more difficult for companies to lay off workers and introduce more rules around compensation.</p><p>   Yet Roy Bahat, head of venture capital firm Bloomberg Beta, said he doubted investors would pass up the chance to invest in a hot startup because it had a unionized workforce. </p><p>   \"In the same way that (venture capitalists) overcome lots of obstacles to investing – everything from PR dilemmas to regulatory vulnerabilities to cofounder issues – unions are just another aspect of a company,\" Bahat said. \"They’re not fatal.\"</p><p>   In August, Jackson Lewis, a law firm known for its work in union avoidance, released a podcast </p><p>episode titled: “The Unlikely Marriage of Unions and Tech Employees.” Jackson Lewis lawyer Laura Pierson-Scheinberg said she was inspired to record the podcast by the increasing number of calls she received from tech companies inquiring about the prospect of union campaigns. </p><p>   The shift to working from home has weakened ties between companies and workers, creating an opening for unions, Pierson-Scheinberg said. </p><p>   Mapbox is known for its strong ties to nonprofits. But in recent years, some workers grew worried about how the mapping technology was being used by clients, one current and one former employee said.</p><p>   Mapbox’s relationship with software company Palantir Technologies Inc    was of particular concern, one former employee said. Workers also wanted to formalize support for colleagues in the event of future layoffs.</p><p>   Palantir could not immediately be reached for comment.</p><p>   On their website, members of the Mapbox Workers Union wrote that they banded together \"to build a lasting, accountable, inclusive Mapbox.\"</p><p>   Mapbox management presented a variety of arguments against unionization, but funding concerns were especially resonant with workers. As management mentioned the failed investment over Zoom, several workers could be seen shaking their heads, according to one employee. Afterward, some workers who had supported the union told organizers they had had a change of heart.</p><p>   The botched $150 million investment \"was a very large and very scary number,\" one employee said. \"The fear that that instilled didn’t go away.\"</p><p>(Reporting by Julia Love in San Francisco Additional reporting by Krystal Hu in New York Editing by Peter Henderson, Kenneth Li and Matthew Lewis)</p><p>((Julia.Love@thomsonreuters.com, @byJuliaLove; (951) 813-8390))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FOCUS-U.S. tech execs hone approach to counter unions amid growing worker interest</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFOCUS-U.S. tech execs hone approach to counter unions amid growing worker interest\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-11-24 00:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>By Julia Love</p><p>   SAN FRANCISCO, Nov 23 (Reuters) - In June, managers at location data startup Mapbox came to employees with alarming news: The company had lost a $150 million investment, and worker organizing was to blame.</p><p>   Prior to the all-hands meeting over <a href=\"https://laohu8.com/S/ZM\">Zoom</a>, roughly two-thirds of the SoftBank-backed startup’s workers had signed cards indicating their desire to unionize, part of a wave of organizing in Silicon Valley. </p><p>   But after Mapbox management disclosed the botched investment – and said they worried funding trouble would persist if workers formed a union – the tide turned, <a href=\"https://laohu8.com/S/AONE.U\">one</a> current and one former employee said. Workers at Mapbox, which was valued at more than $1 billion in its most recent private funding round and has engaged with so-called blank check companies about going public, voted against unionization in August.</p><p>   Mapbox's response offers a window into how tech companies are pushing back as unions seek to bring workers into the fold. </p><p>   In recent years, the Communications Workers of America and the Office and Professional Employees International Union have launched campaigns in Silicon Valley, organizing workers at startups such as Kickstarter and Glitch. The CWA also formed the Alphabet Workers Union, a so-called minority union that does not have collective bargaining rights.</p><p>   As unions continue engaging with workers, a playbook among tech companies is emerging, according to interviews with tech workers and union organizers: Warn employees about the impact a union would have on the startup’s prospects and, in particular, its ability to raise funds. Remind workers of their privilege to cast doubt on why they need a union. And hire law firms and consultants to help drive the point home.  </p><p>   “Tech firms are willing to do whatever is necessary to keep unions out,” said John Logan, a labor professor at San Francisco State University. “They might think unions are fine for food-processing workers or for miners, but not in the tech sector.” </p><p>   SHIFTING POWER DYNAMIC </p><p>   The unions’ pushes are at an early stage, and it remains to be seen whether they will catch on widely. But the growing receptiveness in a sector long regarded as indifferent to organized labor speaks to a broader renegotiation of power that is playing out between tech companies and their employees, interviews with workers suggest.   </p><p>   For many tech workers, the promise of a generous payday is no longer enough. They also want sound working conditions and assurances that the products they are building will not harm society, tech employees and organizers say.</p><p>   Yet workers at high-risk, high-reward startups are loath to jeopardize the value of their stock options, or put their jobs at risk. That is why warnings about funding can be so effective, said Wes McEnany, a senior CWA campaign lead. </p><p>   In addition to Mapbox, management also said unionization could imperil future funding at Kickstarter and Glitch, according to former employees. Medium Chief Executive Ev Williams told workers that investors might shy away if the union prevailed, McEnany said. </p><p>   \"After considering the benefits and costs, our employees voted overwhelmingly against forming a union,\" Mapbox said in a statement. \"It was their decision to make, and they made it unambiguously. We’re now focused on growing our business and supporting our customers.\" </p><p>   Kickstarter and Glitch declined to comment. Williams did not respond.</p><p>   Under U.S. law, companies may not threaten workers that they will lose their jobs if they unionize, but they can predict adverse consequences, said Gordon Lafer of the University of Oregon's Labor Education and Research Center.  </p><p>   A VERY SCARY NUMBER</p><p>   Some investors and financial advisers interviewed by Reuters said they view unions at startups as a drawback because they make it more difficult for companies to lay off workers and introduce more rules around compensation.</p><p>   Yet Roy Bahat, head of venture capital firm Bloomberg Beta, said he doubted investors would pass up the chance to invest in a hot startup because it had a unionized workforce. </p><p>   \"In the same way that (venture capitalists) overcome lots of obstacles to investing – everything from PR dilemmas to regulatory vulnerabilities to cofounder issues – unions are just another aspect of a company,\" Bahat said. \"They’re not fatal.\"</p><p>   In August, Jackson Lewis, a law firm known for its work in union avoidance, released a podcast </p><p>episode titled: “The Unlikely Marriage of Unions and Tech Employees.” Jackson Lewis lawyer Laura Pierson-Scheinberg said she was inspired to record the podcast by the increasing number of calls she received from tech companies inquiring about the prospect of union campaigns. </p><p>   The shift to working from home has weakened ties between companies and workers, creating an opening for unions, Pierson-Scheinberg said. </p><p>   Mapbox is known for its strong ties to nonprofits. But in recent years, some workers grew worried about how the mapping technology was being used by clients, one current and one former employee said.</p><p>   Mapbox’s relationship with software company Palantir Technologies Inc    was of particular concern, one former employee said. Workers also wanted to formalize support for colleagues in the event of future layoffs.</p><p>   Palantir could not immediately be reached for comment.</p><p>   On their website, members of the Mapbox Workers Union wrote that they banded together \"to build a lasting, accountable, inclusive Mapbox.\"</p><p>   Mapbox management presented a variety of arguments against unionization, but funding concerns were especially resonant with workers. As management mentioned the failed investment over Zoom, several workers could be seen shaking their heads, according to one employee. Afterward, some workers who had supported the union told organizers they had had a change of heart.</p><p>   The botched $150 million investment \"was a very large and very scary number,\" one employee said. \"The fear that that instilled didn’t go away.\"</p><p>(Reporting by Julia Love in San Francisco Additional reporting by Krystal Hu in New York Editing by Peter Henderson, Kenneth Li and Matthew Lewis)</p><p>((Julia.Love@thomsonreuters.com, @byJuliaLove; (951) 813-8390))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2185389143","content_text":"By Julia Love   SAN FRANCISCO, Nov 23 (Reuters) - In June, managers at location data startup Mapbox came to employees with alarming news: The company had lost a $150 million investment, and worker organizing was to blame.   Prior to the all-hands meeting over Zoom, roughly two-thirds of the SoftBank-backed startup’s workers had signed cards indicating their desire to unionize, part of a wave of organizing in Silicon Valley.    But after Mapbox management disclosed the botched investment – and said they worried funding trouble would persist if workers formed a union – the tide turned, one current and one former employee said. Workers at Mapbox, which was valued at more than $1 billion in its most recent private funding round and has engaged with so-called blank check companies about going public, voted against unionization in August.   Mapbox's response offers a window into how tech companies are pushing back as unions seek to bring workers into the fold.    In recent years, the Communications Workers of America and the Office and Professional Employees International Union have launched campaigns in Silicon Valley, organizing workers at startups such as Kickstarter and Glitch. The CWA also formed the Alphabet Workers Union, a so-called minority union that does not have collective bargaining rights.   As unions continue engaging with workers, a playbook among tech companies is emerging, according to interviews with tech workers and union organizers: Warn employees about the impact a union would have on the startup’s prospects and, in particular, its ability to raise funds. Remind workers of their privilege to cast doubt on why they need a union. And hire law firms and consultants to help drive the point home.     “Tech firms are willing to do whatever is necessary to keep unions out,” said John Logan, a labor professor at San Francisco State University. “They might think unions are fine for food-processing workers or for miners, but not in the tech sector.”    SHIFTING POWER DYNAMIC    The unions’ pushes are at an early stage, and it remains to be seen whether they will catch on widely. But the growing receptiveness in a sector long regarded as indifferent to organized labor speaks to a broader renegotiation of power that is playing out between tech companies and their employees, interviews with workers suggest.      For many tech workers, the promise of a generous payday is no longer enough. They also want sound working conditions and assurances that the products they are building will not harm society, tech employees and organizers say.   Yet workers at high-risk, high-reward startups are loath to jeopardize the value of their stock options, or put their jobs at risk. That is why warnings about funding can be so effective, said Wes McEnany, a senior CWA campaign lead.    In addition to Mapbox, management also said unionization could imperil future funding at Kickstarter and Glitch, according to former employees. Medium Chief Executive Ev Williams told workers that investors might shy away if the union prevailed, McEnany said.    \"After considering the benefits and costs, our employees voted overwhelmingly against forming a union,\" Mapbox said in a statement. \"It was their decision to make, and they made it unambiguously. We’re now focused on growing our business and supporting our customers.\"    Kickstarter and Glitch declined to comment. Williams did not respond.   Under U.S. law, companies may not threaten workers that they will lose their jobs if they unionize, but they can predict adverse consequences, said Gordon Lafer of the University of Oregon's Labor Education and Research Center.     A VERY SCARY NUMBER   Some investors and financial advisers interviewed by Reuters said they view unions at startups as a drawback because they make it more difficult for companies to lay off workers and introduce more rules around compensation.   Yet Roy Bahat, head of venture capital firm Bloomberg Beta, said he doubted investors would pass up the chance to invest in a hot startup because it had a unionized workforce.    \"In the same way that (venture capitalists) overcome lots of obstacles to investing – everything from PR dilemmas to regulatory vulnerabilities to cofounder issues – unions are just another aspect of a company,\" Bahat said. \"They’re not fatal.\"   In August, Jackson Lewis, a law firm known for its work in union avoidance, released a podcast episode titled: “The Unlikely Marriage of Unions and Tech Employees.” Jackson Lewis lawyer Laura Pierson-Scheinberg said she was inspired to record the podcast by the increasing number of calls she received from tech companies inquiring about the prospect of union campaigns.    The shift to working from home has weakened ties between companies and workers, creating an opening for unions, Pierson-Scheinberg said.    Mapbox is known for its strong ties to nonprofits. But in recent years, some workers grew worried about how the mapping technology was being used by clients, one current and one former employee said.   Mapbox’s relationship with software company Palantir Technologies Inc    was of particular concern, one former employee said. Workers also wanted to formalize support for colleagues in the event of future layoffs.   Palantir could not immediately be reached for comment.   On their website, members of the Mapbox Workers Union wrote that they banded together \"to build a lasting, accountable, inclusive Mapbox.\"   Mapbox management presented a variety of arguments against unionization, but funding concerns were especially resonant with workers. As management mentioned the failed investment over Zoom, several workers could be seen shaking their heads, according to one employee. Afterward, some workers who had supported the union told organizers they had had a change of heart.   The botched $150 million investment \"was a very large and very scary number,\" one employee said. \"The fear that that instilled didn’t go away.\"(Reporting by Julia Love in San Francisco Additional reporting by Krystal Hu in New York Editing by Peter Henderson, Kenneth Li and Matthew Lewis)((Julia.Love@thomsonreuters.com, @byJuliaLove; (951) 813-8390))","news_type":1,"symbols_score_info":{"839167":1,"839680":1,"839729":1,"839946":1,"GOOGL":0.9,"PLTR":0.9}},"isVote":1,"tweetType":1,"viewCount":461,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877121692,"gmtCreate":1637900430820,"gmtModify":1637900430887,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"Like like like&nbsp;","listText":"Like like like&nbsp;","text":"Like like like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877121692","repostId":"1143359507","repostType":2,"isVote":1,"tweetType":1,"viewCount":567,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872990577,"gmtCreate":1637384144658,"gmtModify":1637384448297,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"Like like like&nbsp;","listText":"Like like like&nbsp;","text":"Like like like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/872990577","repostId":"1120617526","repostType":2,"isVote":1,"tweetType":1,"viewCount":733,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872990164,"gmtCreate":1637384127569,"gmtModify":1637384443959,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"Like the sharing","listText":"Like the sharing","text":"Like the sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872990164","repostId":"1120617526","repostType":2,"isVote":1,"tweetType":1,"viewCount":624,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872904765,"gmtCreate":1637384073758,"gmtModify":1637384073916,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"SG poor stock","listText":"SG poor stock","text":"SG poor stock","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872904765","repostId":"1168345410","repostType":2,"isVote":1,"tweetType":1,"viewCount":807,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872908788,"gmtCreate":1637383540305,"gmtModify":1637383540469,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"Like like like&nbsp;","listText":"Like like like&nbsp;","text":"Like like like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872908788","repostId":"1180752156","repostType":2,"isVote":1,"tweetType":1,"viewCount":511,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878049207,"gmtCreate":1637129041957,"gmtModify":1637129217128,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094271228114110","authorIdStr":"4094271228114110"},"themes":[],"htmlText":"Very hard to select a good stock with good returns&nbsp;","listText":"Very hard to select a good stock with good returns&nbsp;","text":"Very hard to select a good stock with good returns","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878049207","repostId":"1185179037","repostType":2,"isVote":1,"tweetType":1,"viewCount":652,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":864446371,"gmtCreate":1633142134633,"gmtModify":1633142134769,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/864446371","repostId":"1199143925","repostType":2,"repost":{"id":"1199143925","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633078771,"share":"https://ttm.financial/m/news/1199143925?lang=&edition=full","pubTime":"2021-10-01 16:59","market":"us","language":"en","title":"Top 10 stocks that Wall Street’s picks for Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=1199143925","media":"Tiger Newspress","summary":"To find the names Wall Street thinks could take the market higher in th fourth quarter, CNBC Pro ide","content":"<p>To find the names Wall Street thinks could take the market higher in th fourth quarter, CNBC Pro identified the stocks with at least 70% of analysts say to buy. We then found the top 10 stocks from that pool ranked by consensus 12-month price target upside.</p>\n<p>Take a look at CNBC Pro’s list.<img src=\"https://static.tigerbbs.com/5ae083b97e4feaf3496a1e1d77d78429\" tg-width=\"1360\" tg-height=\"1466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Topping the list for potential upside is News Corp, the parent company of The Wall Street Journal-publisher Dow Jones. Analysts on average see the stock rallying 37.4% in the next 12-months. The stock is also outperforming the market this year, rising 33% compared with the S&amp;P 500′s 16% gain.</p>\n<p>Alaska Air Group is the most liked stock on the Street from the screen. The airline stock has a buy rating from 93% of analysts covering the name. Analysts think Alaska Air can rise 27.7% in the next year.</p>\n<p>Power generator company Generac makes CNBC Pro’s screen and has the best year-to-date performance out of the list. The stock has gained nearly 80% as of Wednesday’s close. Wall Street thinks Generac has more room to run with consensus potential upside of 25.4%.</p>\n<p>Other names to make CNBC Pro’s screen include General Motors, T-Mobile and PayPal.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top 10 stocks that Wall Street’s picks for Q4</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop 10 stocks that Wall Street’s picks for Q4\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-01 16:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>To find the names Wall Street thinks could take the market higher in th fourth quarter, CNBC Pro identified the stocks with at least 70% of analysts say to buy. We then found the top 10 stocks from that pool ranked by consensus 12-month price target upside.</p>\n<p>Take a look at CNBC Pro’s list.<img src=\"https://static.tigerbbs.com/5ae083b97e4feaf3496a1e1d77d78429\" tg-width=\"1360\" tg-height=\"1466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Topping the list for potential upside is News Corp, the parent company of The Wall Street Journal-publisher Dow Jones. Analysts on average see the stock rallying 37.4% in the next 12-months. The stock is also outperforming the market this year, rising 33% compared with the S&amp;P 500′s 16% gain.</p>\n<p>Alaska Air Group is the most liked stock on the Street from the screen. The airline stock has a buy rating from 93% of analysts covering the name. Analysts think Alaska Air can rise 27.7% in the next year.</p>\n<p>Power generator company Generac makes CNBC Pro’s screen and has the best year-to-date performance out of the list. The stock has gained nearly 80% as of Wednesday’s close. Wall Street thinks Generac has more room to run with consensus potential upside of 25.4%.</p>\n<p>Other names to make CNBC Pro’s screen include General Motors, T-Mobile and PayPal.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GM":"通用汽车","TMUS":"T-Mobile US Inc","NWSA":"新闻集团"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199143925","content_text":"To find the names Wall Street thinks could take the market higher in th fourth quarter, CNBC Pro identified the stocks with at least 70% of analysts say to buy. We then found the top 10 stocks from that pool ranked by consensus 12-month price target upside.\nTake a look at CNBC Pro’s list.Topping the list for potential upside is News Corp, the parent company of The Wall Street Journal-publisher Dow Jones. Analysts on average see the stock rallying 37.4% in the next 12-months. The stock is also outperforming the market this year, rising 33% compared with the S&P 500′s 16% gain.\nAlaska Air Group is the most liked stock on the Street from the screen. The airline stock has a buy rating from 93% of analysts covering the name. Analysts think Alaska Air can rise 27.7% in the next year.\nPower generator company Generac makes CNBC Pro’s screen and has the best year-to-date performance out of the list. The stock has gained nearly 80% as of Wednesday’s close. Wall Street thinks Generac has more room to run with consensus potential upside of 25.4%.\nOther names to make CNBC Pro’s screen include General Motors, T-Mobile and PayPal.","news_type":1,"symbols_score_info":{"GM":0.9,"NWSA":0.9,"TMUS":0.9}},"isVote":1,"tweetType":1,"viewCount":224,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823710937,"gmtCreate":1633660632608,"gmtModify":1633660632807,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"True ?","listText":"True ?","text":"True ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/823710937","repostId":"1163018074","repostType":4,"repost":{"id":"1163018074","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1633646971,"share":"https://ttm.financial/m/news/1163018074?lang=&edition=full","pubTime":"2021-10-08 06:49","market":"us","language":"en","title":"Wall Street ends day with solid gains; investors hail U.S. debt-ceiling truce","url":"https://stock-news.laohu8.com/highlight/detail?id=1163018074","media":"Reuters","summary":"U.S. Senate rushes to advance $480 bln debt-limit increase\nU.S. weekly jobless claims fall sharply\nC","content":"<ul>\n <li>U.S. Senate rushes to advance $480 bln debt-limit increase</li>\n <li>U.S. weekly jobless claims fall sharply</li>\n <li>Consumer discretionary and materials lead sectors</li>\n <li>Levi Strauss shares soar after profit beat</li>\n <li>Indexes jump: Dow 0.98%, S&amp;P 0.83%, Nasdaq 1.05%</li>\n</ul>\n<p>Oct 7 (Reuters) - Wall Street ended sharply higher on Thursday in a broad-based rally led by Big Tech, as a truce in the debt-ceiling standoff in the U.S. Congress relieved concerns of a possible government debt default this month.</p>\n<p>Mega-cap stocks jumped with Apple Inc&nbsp;up 0.9% and Amazon.com Inc&nbsp;rising 1.2%, the biggest boosts to the S&amp;P 500 and Nasdaq. Tesla&nbsp;and Google-parent Alphabet&nbsp;both rose more than 1%.</p>\n<p>The U.S. Senate took a step toward passing a $480 billion increase in Treasury Department borrowing authority, which would put off another partisan showdown until December.</p>\n<p>Uncertainty over the debt-ceiling negotiations was one concern investors cited in September as the S&amp;P 500 logged its biggest monthly percentage drop since the onset of the coronavirus pandemic in March 2020.</p>\n<p>\"Today's (market) is driven by a slight move in Washington towards rationality about being able to pay their bills, write some checks,\" said Kim Forrest, chief investment officer at Bokeh Capital Partners in Pittsburgh.</p>\n<p>Meanwhile, data showed the number of Americans filing new claims for jobless benefits dropped last week by the most in three months, suggesting the labor market recovery was regaining momentum as the latest wave of COVID-19 infections began to subside.</p>\n<p>The closely watched monthly U.S. jobs report is due on Friday.</p>\n<p>“Today’s numbers reinforce the expectation that employment will take a significant step up in the coming months, and I think that’s positive for the economy,” said Brad Neuman, director of market strategy at Alger.</p>\n<p>\"The market climbed its wall of worry today as fears of a debt-ceiling impasse receded and hopes for an acceleration in employment gains were reinforced.”</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 0.98% to end at 34,754.94 points, while the S&amp;P 500&nbsp;gained 0.83% to 4,399.76.</p>\n<p>The Nasdaq Composite&nbsp;climbed 1.05% to 14,654.02.</p>\n<p>The S&amp;P 500 materials index&nbsp;jumped 1.35% and the consumer discretionary index&nbsp;rallied 1.50%, both leading among 11 sectors.</p>\n<p>U.S.-traded Chinese stocks Alibaba Group Holding&nbsp;and Tencent Holdings&nbsp;each surged about 8% as concerns around U.S.-Sino trade relations and Evergrande's&nbsp;debt crisis appeared to ease.</p>\n<p>Investors will watch third-quarter earnings reports that start to arrive in earnest next week. Analysts on average estimate S&amp;P 500 companies' earnings per share rose 29% in the third quarter, according to Refinitiv.</p>\n<p>Levi Strauss &amp; Co&nbsp;shares jumped 8.5% after the jeans maker beat third-quarter revenue and profit estimates.</p>\n<p>Volume on U.S. exchanges was 10.1 billion shares, compared with the 11 billion average over the last 20 trading days.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.50-to-1 ratio; on Nasdaq, a 2.49-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 31 new 52-week highs and four new lows; the Nasdaq Composite recorded 93 new highs and 80 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends day with solid gains; investors hail U.S. debt-ceiling truce</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends day with solid gains; investors hail U.S. debt-ceiling truce\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-10-08 06:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>U.S. Senate rushes to advance $480 bln debt-limit increase</li>\n <li>U.S. weekly jobless claims fall sharply</li>\n <li>Consumer discretionary and materials lead sectors</li>\n <li>Levi Strauss shares soar after profit beat</li>\n <li>Indexes jump: Dow 0.98%, S&amp;P 0.83%, Nasdaq 1.05%</li>\n</ul>\n<p>Oct 7 (Reuters) - Wall Street ended sharply higher on Thursday in a broad-based rally led by Big Tech, as a truce in the debt-ceiling standoff in the U.S. Congress relieved concerns of a possible government debt default this month.</p>\n<p>Mega-cap stocks jumped with Apple Inc&nbsp;up 0.9% and Amazon.com Inc&nbsp;rising 1.2%, the biggest boosts to the S&amp;P 500 and Nasdaq. Tesla&nbsp;and Google-parent Alphabet&nbsp;both rose more than 1%.</p>\n<p>The U.S. Senate took a step toward passing a $480 billion increase in Treasury Department borrowing authority, which would put off another partisan showdown until December.</p>\n<p>Uncertainty over the debt-ceiling negotiations was one concern investors cited in September as the S&amp;P 500 logged its biggest monthly percentage drop since the onset of the coronavirus pandemic in March 2020.</p>\n<p>\"Today's (market) is driven by a slight move in Washington towards rationality about being able to pay their bills, write some checks,\" said Kim Forrest, chief investment officer at Bokeh Capital Partners in Pittsburgh.</p>\n<p>Meanwhile, data showed the number of Americans filing new claims for jobless benefits dropped last week by the most in three months, suggesting the labor market recovery was regaining momentum as the latest wave of COVID-19 infections began to subside.</p>\n<p>The closely watched monthly U.S. jobs report is due on Friday.</p>\n<p>“Today’s numbers reinforce the expectation that employment will take a significant step up in the coming months, and I think that’s positive for the economy,” said Brad Neuman, director of market strategy at Alger.</p>\n<p>\"The market climbed its wall of worry today as fears of a debt-ceiling impasse receded and hopes for an acceleration in employment gains were reinforced.”</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 0.98% to end at 34,754.94 points, while the S&amp;P 500&nbsp;gained 0.83% to 4,399.76.</p>\n<p>The Nasdaq Composite&nbsp;climbed 1.05% to 14,654.02.</p>\n<p>The S&amp;P 500 materials index&nbsp;jumped 1.35% and the consumer discretionary index&nbsp;rallied 1.50%, both leading among 11 sectors.</p>\n<p>U.S.-traded Chinese stocks Alibaba Group Holding&nbsp;and Tencent Holdings&nbsp;each surged about 8% as concerns around U.S.-Sino trade relations and Evergrande's&nbsp;debt crisis appeared to ease.</p>\n<p>Investors will watch third-quarter earnings reports that start to arrive in earnest next week. Analysts on average estimate S&amp;P 500 companies' earnings per share rose 29% in the third quarter, according to Refinitiv.</p>\n<p>Levi Strauss &amp; Co&nbsp;shares jumped 8.5% after the jeans maker beat third-quarter revenue and profit estimates.</p>\n<p>Volume on U.S. exchanges was 10.1 billion shares, compared with the 11 billion average over the last 20 trading days.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.50-to-1 ratio; on Nasdaq, a 2.49-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 31 new 52-week highs and four new lows; the Nasdaq Composite recorded 93 new highs and 80 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LEVI":"李维斯",".DJI":"道琼斯","TCEHY":"腾讯控股ADR",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite","AMZN":"亚马逊","BABA":"阿里巴巴","TSLA":"特斯拉","AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163018074","content_text":"U.S. Senate rushes to advance $480 bln debt-limit increase\nU.S. weekly jobless claims fall sharply\nConsumer discretionary and materials lead sectors\nLevi Strauss shares soar after profit beat\nIndexes jump: Dow 0.98%, S&P 0.83%, Nasdaq 1.05%\n\nOct 7 (Reuters) - Wall Street ended sharply higher on Thursday in a broad-based rally led by Big Tech, as a truce in the debt-ceiling standoff in the U.S. Congress relieved concerns of a possible government debt default this month.\nMega-cap stocks jumped with Apple Inc up 0.9% and Amazon.com Inc rising 1.2%, the biggest boosts to the S&P 500 and Nasdaq. Tesla and Google-parent Alphabet both rose more than 1%.\nThe U.S. Senate took a step toward passing a $480 billion increase in Treasury Department borrowing authority, which would put off another partisan showdown until December.\nUncertainty over the debt-ceiling negotiations was one concern investors cited in September as the S&P 500 logged its biggest monthly percentage drop since the onset of the coronavirus pandemic in March 2020.\n\"Today's (market) is driven by a slight move in Washington towards rationality about being able to pay their bills, write some checks,\" said Kim Forrest, chief investment officer at Bokeh Capital Partners in Pittsburgh.\nMeanwhile, data showed the number of Americans filing new claims for jobless benefits dropped last week by the most in three months, suggesting the labor market recovery was regaining momentum as the latest wave of COVID-19 infections began to subside.\nThe closely watched monthly U.S. jobs report is due on Friday.\n“Today’s numbers reinforce the expectation that employment will take a significant step up in the coming months, and I think that’s positive for the economy,” said Brad Neuman, director of market strategy at Alger.\n\"The market climbed its wall of worry today as fears of a debt-ceiling impasse receded and hopes for an acceleration in employment gains were reinforced.”\nThe Dow Jones Industrial Average rose 0.98% to end at 34,754.94 points, while the S&P 500 gained 0.83% to 4,399.76.\nThe Nasdaq Composite climbed 1.05% to 14,654.02.\nThe S&P 500 materials index jumped 1.35% and the consumer discretionary index rallied 1.50%, both leading among 11 sectors.\nU.S.-traded Chinese stocks Alibaba Group Holding and Tencent Holdings each surged about 8% as concerns around U.S.-Sino trade relations and Evergrande's debt crisis appeared to ease.\nInvestors will watch third-quarter earnings reports that start to arrive in earnest next week. Analysts on average estimate S&P 500 companies' earnings per share rose 29% in the third quarter, according to Refinitiv.\nLevi Strauss & Co shares jumped 8.5% after the jeans maker beat third-quarter revenue and profit estimates.\nVolume on U.S. exchanges was 10.1 billion shares, compared with the 11 billion average over the last 20 trading days.\nAdvancing issues outnumbered declining ones on the NYSE by a 2.50-to-1 ratio; on Nasdaq, a 2.49-to-1 ratio favored advancers.\nThe S&P 500 posted 31 new 52-week highs and four new lows; the Nasdaq Composite recorded 93 new highs and 80 new lows.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"AAPL":0.9,"AMZN":0.9,"BABA":0.9,"LEVI":0.9,"TCEHY":0.9,"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":274,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841171159,"gmtCreate":1635898607269,"gmtModify":1635898607269,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>even 100% fly also hard to make profit at least 2yrs","listText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>even 100% fly also hard to make profit at least 2yrs","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$even 100% fly also hard to make profit at least 2yrs","images":[{"img":"https://static.tigerbbs.com/63eb7af4d5d248e1fb7f40ebba9f871e","width":"1080","height":"3444"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/841171159","isVote":1,"tweetType":1,"viewCount":1119,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":866278996,"gmtCreate":1632787863715,"gmtModify":1632797591094,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/866278996","repostId":"2170624172","repostType":4,"repost":{"id":"2170624172","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1632772840,"share":"https://ttm.financial/m/news/2170624172?lang=&edition=full","pubTime":"2021-09-28 04:00","market":"us","language":"en","title":"Tech pulls Nasdaq to lower close as Treasury yields rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2170624172","media":"Reuters","summary":"NEW YORK, Sept 27 (Reuters) - Wall Street ended mixed on Monday as investors began the last week of ","content":"<p>NEW YORK, Sept 27 (Reuters) - Wall Street ended mixed on Monday as investors began the last week of September and the quarter with a pivot to value as tech shares, hurt by rising Treasury yields, weighed on the Nasdaq Composite index .</p>\n<p>The S&amp;P 500 index joined the Nasdaq in negative territory, but the blue-chip Dow Jones Industrial Average ended higher.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;outperformed the broader market.</p>\n<p>\"The economic reopening trade is alive and well,\" said Chuck Carlson, chief executive of Horizon Investment Services in Hammond, Indiana. \"Economically sensitive stocks are up, and tech’s being worked over pretty good.\"</p>\n<p>Benchmark U.S. Treasury yields rose, to the benefit of rate-sensitive financials. Rising crude prices</p>\n<p>pushed energy stocks to a higher close.</p>\n<p>\"Rising rates typically reflect investors having a little bit more confidence in the economy not being stalled out,\" Carlson added. \"And the Fed is also indicating it's going to start tapering sooner rather later, and that's probably helping upward trajectory in rates.\"</p>\n<p>Those rising yields hurt some market leaders that had benefited from low rates. Microsoft Corp, Apple Inc, Amazon.com Inc and Alphabet Inc and all lost ground.</p>\n<p>In Washington, negotiations over funding the government and raising the debt ceiling were heating up at the start of a week that could also include a vote on U.S. President Biden's $1 trillion infrastructure bill.</p>\n<p>On the economic front, new orders for durable goods waltzed past analyst expectations, gaining 1.8% in August. The value of total new orders has grown beyond pre-pandemic levels to a seven-year high.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 72.95 points, or 0.21%, to 34,870.95, the S&amp;P 500 lost 12.27 points, or 0.28%, to 4,443.21 and the Nasdaq Composite&nbsp;dropped 75.77 points, or 0.5%, to 14,971.93.</p>\n<p>While the S&amp;P 500 value index has underperformed growth so far this year, that gap has narrowed in September as investors increasingly favor lower valuation stocks that stand to benefit most from economic revival.</p>\n<p>The S&amp;P 500 is on track to snap its seven-month winning streak, with the prospect of higher corporate tax rates and hints from the U.S. Federal Reserve that it could start to tighten its accommodative monetary policies in the months ahead.</p>\n<p>Goldman Sachs strategists see potential corporate rate hikes as a headwind to its outlook for return-on-equity (ROE) on U.S. stocks in 2022, the broker said in a research note.</p>\n<p>(Reporting by Stephen Culp; Additional reporting by Devik Jain in Bengaluru; Editing by Richard Chang)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tech pulls Nasdaq to lower close as Treasury yields rise</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTech pulls Nasdaq to lower close as Treasury yields rise\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-28 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, Sept 27 (Reuters) - Wall Street ended mixed on Monday as investors began the last week of September and the quarter with a pivot to value as tech shares, hurt by rising Treasury yields, weighed on the Nasdaq Composite index .</p>\n<p>The S&amp;P 500 index joined the Nasdaq in negative territory, but the blue-chip Dow Jones Industrial Average ended higher.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;outperformed the broader market.</p>\n<p>\"The economic reopening trade is alive and well,\" said Chuck Carlson, chief executive of Horizon Investment Services in Hammond, Indiana. \"Economically sensitive stocks are up, and tech’s being worked over pretty good.\"</p>\n<p>Benchmark U.S. Treasury yields rose, to the benefit of rate-sensitive financials. Rising crude prices</p>\n<p>pushed energy stocks to a higher close.</p>\n<p>\"Rising rates typically reflect investors having a little bit more confidence in the economy not being stalled out,\" Carlson added. \"And the Fed is also indicating it's going to start tapering sooner rather later, and that's probably helping upward trajectory in rates.\"</p>\n<p>Those rising yields hurt some market leaders that had benefited from low rates. Microsoft Corp, Apple Inc, Amazon.com Inc and Alphabet Inc and all lost ground.</p>\n<p>In Washington, negotiations over funding the government and raising the debt ceiling were heating up at the start of a week that could also include a vote on U.S. President Biden's $1 trillion infrastructure bill.</p>\n<p>On the economic front, new orders for durable goods waltzed past analyst expectations, gaining 1.8% in August. The value of total new orders has grown beyond pre-pandemic levels to a seven-year high.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 72.95 points, or 0.21%, to 34,870.95, the S&amp;P 500 lost 12.27 points, or 0.28%, to 4,443.21 and the Nasdaq Composite&nbsp;dropped 75.77 points, or 0.5%, to 14,971.93.</p>\n<p>While the S&amp;P 500 value index has underperformed growth so far this year, that gap has narrowed in September as investors increasingly favor lower valuation stocks that stand to benefit most from economic revival.</p>\n<p>The S&amp;P 500 is on track to snap its seven-month winning streak, with the prospect of higher corporate tax rates and hints from the U.S. Federal Reserve that it could start to tighten its accommodative monetary policies in the months ahead.</p>\n<p>Goldman Sachs strategists see potential corporate rate hikes as a headwind to its outlook for return-on-equity (ROE) on U.S. stocks in 2022, the broker said in a research note.</p>\n<p>(Reporting by Stephen Culp; Additional reporting by Devik Jain in Bengaluru; Editing by Richard Chang)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","FB":"ProShares S&P 500 Dynamic Buffer ETF","AAPL":"苹果","MSFT":"微软","GOOGL":"谷歌A","GS":"高盛"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2170624172","content_text":"NEW YORK, Sept 27 (Reuters) - Wall Street ended mixed on Monday as investors began the last week of September and the quarter with a pivot to value as tech shares, hurt by rising Treasury yields, weighed on the Nasdaq Composite index .\nThe S&P 500 index joined the Nasdaq in negative territory, but the blue-chip Dow Jones Industrial Average ended higher.\nEconomically sensitive smallcaps and transports outperformed the broader market.\n\"The economic reopening trade is alive and well,\" said Chuck Carlson, chief executive of Horizon Investment Services in Hammond, Indiana. \"Economically sensitive stocks are up, and tech’s being worked over pretty good.\"\nBenchmark U.S. Treasury yields rose, to the benefit of rate-sensitive financials. Rising crude prices\npushed energy stocks to a higher close.\n\"Rising rates typically reflect investors having a little bit more confidence in the economy not being stalled out,\" Carlson added. \"And the Fed is also indicating it's going to start tapering sooner rather later, and that's probably helping upward trajectory in rates.\"\nThose rising yields hurt some market leaders that had benefited from low rates. Microsoft Corp, Apple Inc, Amazon.com Inc and Alphabet Inc and all lost ground.\nIn Washington, negotiations over funding the government and raising the debt ceiling were heating up at the start of a week that could also include a vote on U.S. President Biden's $1 trillion infrastructure bill.\nOn the economic front, new orders for durable goods waltzed past analyst expectations, gaining 1.8% in August. The value of total new orders has grown beyond pre-pandemic levels to a seven-year high.\nUnofficially, the Dow Jones Industrial Average rose 72.95 points, or 0.21%, to 34,870.95, the S&P 500 lost 12.27 points, or 0.28%, to 4,443.21 and the Nasdaq Composite dropped 75.77 points, or 0.5%, to 14,971.93.\nWhile the S&P 500 value index has underperformed growth so far this year, that gap has narrowed in September as investors increasingly favor lower valuation stocks that stand to benefit most from economic revival.\nThe S&P 500 is on track to snap its seven-month winning streak, with the prospect of higher corporate tax rates and hints from the U.S. Federal Reserve that it could start to tighten its accommodative monetary policies in the months ahead.\nGoldman Sachs strategists see potential corporate rate hikes as a headwind to its outlook for return-on-equity (ROE) on U.S. stocks in 2022, the broker said in a research note.\n(Reporting by Stephen Culp; Additional reporting by Devik Jain in Bengaluru; Editing by Richard Chang)","news_type":1,"symbols_score_info":{"AAPL":0.9,"AMZN":0.9,"FB":0.9,"NQmain":0.9,"GOOGL":0.9,"GS":0.9,"MSFT":0.9}},"isVote":1,"tweetType":1,"viewCount":348,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866275239,"gmtCreate":1632788020321,"gmtModify":1632797590496,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/866275239","repostId":"2170610313","repostType":4,"repost":{"id":"2170610313","kind":"highlight","pubTimestamp":1632748322,"share":"https://ttm.financial/m/news/2170610313?lang=&edition=full","pubTime":"2021-09-27 21:12","market":"us","language":"en","title":"Got $1,000? 3 Buffett Stocks to Buy and Hold Forever","url":"https://stock-news.laohu8.com/highlight/detail?id=2170610313","media":"Motley Fool","summary":"Seeking profits? Follow one of history's most successful investors.","content":"<p>It's almost hard to believe how successful <b>Berkshire Hathaway</b> (NYSE:BRK.A)(NYSE:BRK.B) has been since Warren Buffett took over as the company's CEO in 1965. Back then, the company's stock was priced at $19 per share. Today, a single share of the company's class A stock is valued at roughly $418,000. That means that a $1,000 stake in the company at the beginning of Buffett's tenure would now be worth about $22 million. Not too shabby.</p>\n<p>Berkshire's most explosive days of growth may be in the rearview mirror, but the company already has one of the most impressive investment legacies in history, and a panel of Motley Fool contributors has identified three Buffett-backed companies that are poised to keep winning. Read on to see why they think that these stocks will help you beat the market.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/859b714929f75d0b443ee7f0a5afa9c6\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: The Motley Fool.</span></p>\n<h2><b>One of Buffett's all-time favorite stocks</b></h2>\n<p><b>Keith Noonan:&nbsp;</b>With its leading role in the mobile computing revolution, <b>Apple</b> (NASDAQ:AAPL) stands as one of the most influential companies of the last half-century. It's also one of the stock market's all-time great success stories and has created generational wealth for investors who bought at opportune times and held on to their positions.</p>\n<p>Apple's strong brand and design expertise has allowed it to build one of the most loyal customer bases in the world and generate profits that absolutely trounce its competitors in the mobile computing market. The company has also used its dominant position in mobile to build a hugely profitable software ecosystem, rolling out its own subscription services and charging a commission on applications sold through its App Store.</p>\n<p>So entrenched and numerous are the company's strengths that Buffett moved to make Apple Berkshire Hathaway's single largest stock holding, and The Oracle of Omaha has been effusive in his praise for the tech giant. In 2020, he said that it was probably the best business he knew of, and this year he hailed CEO Tim Cook as \"one of the best managers in the world.\" That's noteworthy praise from a man who is famously brilliant at identifying quality companies that have what it takes to be big long-term winners.</p>\n<p>In addition to its mobile and software businesses and early success in the wearables market, Apple appears to be on the verge of benefiting from potentially revolutionary technology shifts including 5G and augmented reality. There's a good chance it will continue to spearhead new tech and services movements that have far-reaching impacts.</p>\n<p>Even better, Apple also pays a dividend, and shareholders can look forward to big payout growth over the long term. The company has boosted its annual payout each year since initiating a dividend in 2012, and its payout ratio remains at a relatively low level that opens the door for continued dividend hikes.</p>\n<p>This is one industry leader that looks poised to go the distance.</p>\n<h2>\"Mastering\" the future of electronic payments</h2>\n<p><b>Jason Hall:</b> Fintech is a hot space for investors, with so many companies working to disrupt the status quo in the financial services industry. And the fact is, there has never been a better time to be a user of financial products. But with that said, it's a mistake to ignore a stalwart like <b>Mastercard</b> (NYSE:MA) when looking for ways to profit from the changing ways money changes hands.</p>\n<p>As a starting point, Mastercard is an innovator in this space. Over the past few years, it has invested heavily in technology to make it easier for people and merchants around the world to transact, including the huge opportunity in business-to-business, or B2B, payments market. To put it simply, Mastercard isn't playing defense while the upstarts of the world take share from it: The company is fully on offense, adding more features and entering new markets to attract more users to its massive, secure, and well-known payments platforms.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0ec5b64c7b1d92db3d5d5b240d643771\" tg-width=\"720\" tg-height=\"449\" width=\"100%\" height=\"auto\"><span>MA Dividend data by YCharts</span></p>\n<p>Lastly, Mastercard's network effect, underpinned by the trio of merchants, consumers, and financial services providers, all want access to one another. The more of each group that is in the Mastercard family, the more appealing it becomes to the other cohorts.</p>\n<p>With the global middle class adding about 1 billion new members over the coming decade, and technology that gives even more people access to electronic payments becoming commonplace, this long-term winner should keep winning for many years to come.</p>\n<h2>You don't have to pick just one Buffett stock -- here's how to own them all</h2>\n<p><b>Jamal Carnette: </b>Instead of picking one \"Buffett stock,\" aka a stock from Berkshire Hathaway's portfolio of companies, why not own them all? The easiest way to do this is to buy shares of Berkshire Hathaway itself. As of year-end 2020, more than half of Berkshire's value is due to its minority position in companies like Apple, <b>Bank of America</b>, and <b>The</b> <b>Coca-Cola</b> <b>Company</b>.</p>\n<p>But wait, there's more... In addition to owning these companies you have ownership of Berkshire Hathaway's operating companies -- companies in which it owns a controlling stake -- including GEICO, BNSF Railroad, and Berkshire Hathaway Energy (BHE). In fact, Berkshire's operating companies could be better poised to take advantage of recent economic conditions.</p>\n<p>We all know the supply chain is breaking. As a result, transportation costs are exploding and allowing BNSF to charge premium freight rates. The Federal Reserve is finally discussing raising interest rates, which will let GEICO better profit from its near-$150 billion float. BHE is also poised for strong growth as earlier investments in the grid and clean energy now seem prescient considering recent grid failures and an increased desire among Americans to lower carbon emissions.</p>\n<p>But wait... there's even more. Finally, you get two of the greatest capital allocators in the history of modern capitalism making decisions on how to employ future cash flow at a valuation discount to the overall market. Last year this was on full display when Berkshire repurchased nearly $25 billion of its own shares, a figure then equal to 5.2% of its market capitalization.</p>\n<p>Warren Buffett owns many strong portfolio companies, but you don't have to pick just one if you own shares of Berkshire Hathaway.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 3 Buffett Stocks to Buy and Hold Forever</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 3 Buffett Stocks to Buy and Hold Forever\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-27 21:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/26/got-1000-3-buffett-stocks-to-buy-and-hold-forever/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's almost hard to believe how successful Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) has been since Warren Buffett took over as the company's CEO in 1965. Back then, the company's stock was priced ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/26/got-1000-3-buffett-stocks-to-buy-and-hold-forever/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果","MA":"万事达","KO":"可口可乐","BAC":"美国银行","BRK.A":"伯克希尔","BRK.B":"伯克希尔B"},"source_url":"https://www.fool.com/investing/2021/09/26/got-1000-3-buffett-stocks-to-buy-and-hold-forever/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2170610313","content_text":"It's almost hard to believe how successful Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) has been since Warren Buffett took over as the company's CEO in 1965. Back then, the company's stock was priced at $19 per share. Today, a single share of the company's class A stock is valued at roughly $418,000. That means that a $1,000 stake in the company at the beginning of Buffett's tenure would now be worth about $22 million. Not too shabby.\nBerkshire's most explosive days of growth may be in the rearview mirror, but the company already has one of the most impressive investment legacies in history, and a panel of Motley Fool contributors has identified three Buffett-backed companies that are poised to keep winning. Read on to see why they think that these stocks will help you beat the market.\nImage source: The Motley Fool.\nOne of Buffett's all-time favorite stocks\nKeith Noonan: With its leading role in the mobile computing revolution, Apple (NASDAQ:AAPL) stands as one of the most influential companies of the last half-century. It's also one of the stock market's all-time great success stories and has created generational wealth for investors who bought at opportune times and held on to their positions.\nApple's strong brand and design expertise has allowed it to build one of the most loyal customer bases in the world and generate profits that absolutely trounce its competitors in the mobile computing market. The company has also used its dominant position in mobile to build a hugely profitable software ecosystem, rolling out its own subscription services and charging a commission on applications sold through its App Store.\nSo entrenched and numerous are the company's strengths that Buffett moved to make Apple Berkshire Hathaway's single largest stock holding, and The Oracle of Omaha has been effusive in his praise for the tech giant. In 2020, he said that it was probably the best business he knew of, and this year he hailed CEO Tim Cook as \"one of the best managers in the world.\" That's noteworthy praise from a man who is famously brilliant at identifying quality companies that have what it takes to be big long-term winners.\nIn addition to its mobile and software businesses and early success in the wearables market, Apple appears to be on the verge of benefiting from potentially revolutionary technology shifts including 5G and augmented reality. There's a good chance it will continue to spearhead new tech and services movements that have far-reaching impacts.\nEven better, Apple also pays a dividend, and shareholders can look forward to big payout growth over the long term. The company has boosted its annual payout each year since initiating a dividend in 2012, and its payout ratio remains at a relatively low level that opens the door for continued dividend hikes.\nThis is one industry leader that looks poised to go the distance.\n\"Mastering\" the future of electronic payments\nJason Hall: Fintech is a hot space for investors, with so many companies working to disrupt the status quo in the financial services industry. And the fact is, there has never been a better time to be a user of financial products. But with that said, it's a mistake to ignore a stalwart like Mastercard (NYSE:MA) when looking for ways to profit from the changing ways money changes hands.\nAs a starting point, Mastercard is an innovator in this space. Over the past few years, it has invested heavily in technology to make it easier for people and merchants around the world to transact, including the huge opportunity in business-to-business, or B2B, payments market. To put it simply, Mastercard isn't playing defense while the upstarts of the world take share from it: The company is fully on offense, adding more features and entering new markets to attract more users to its massive, secure, and well-known payments platforms.\nMA Dividend data by YCharts\nLastly, Mastercard's network effect, underpinned by the trio of merchants, consumers, and financial services providers, all want access to one another. The more of each group that is in the Mastercard family, the more appealing it becomes to the other cohorts.\nWith the global middle class adding about 1 billion new members over the coming decade, and technology that gives even more people access to electronic payments becoming commonplace, this long-term winner should keep winning for many years to come.\nYou don't have to pick just one Buffett stock -- here's how to own them all\nJamal Carnette: Instead of picking one \"Buffett stock,\" aka a stock from Berkshire Hathaway's portfolio of companies, why not own them all? The easiest way to do this is to buy shares of Berkshire Hathaway itself. As of year-end 2020, more than half of Berkshire's value is due to its minority position in companies like Apple, Bank of America, and The Coca-Cola Company.\nBut wait, there's more... In addition to owning these companies you have ownership of Berkshire Hathaway's operating companies -- companies in which it owns a controlling stake -- including GEICO, BNSF Railroad, and Berkshire Hathaway Energy (BHE). In fact, Berkshire's operating companies could be better poised to take advantage of recent economic conditions.\nWe all know the supply chain is breaking. As a result, transportation costs are exploding and allowing BNSF to charge premium freight rates. The Federal Reserve is finally discussing raising interest rates, which will let GEICO better profit from its near-$150 billion float. BHE is also poised for strong growth as earlier investments in the grid and clean energy now seem prescient considering recent grid failures and an increased desire among Americans to lower carbon emissions.\nBut wait... there's even more. Finally, you get two of the greatest capital allocators in the history of modern capitalism making decisions on how to employ future cash flow at a valuation discount to the overall market. Last year this was on full display when Berkshire repurchased nearly $25 billion of its own shares, a figure then equal to 5.2% of its market capitalization.\nWarren Buffett owns many strong portfolio companies, but you don't have to pick just one if you own shares of Berkshire Hathaway.","news_type":1,"symbols_score_info":{"AAPL":0.9,"BAC":0.9,"BRK.A":0.9,"BRK.B":0.9,"KO":0.9,"MA":0.9}},"isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691460142,"gmtCreate":1640228331608,"gmtModify":1640228331764,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"Like like like&nbsp;","listText":"Like like like&nbsp;","text":"Like like like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691460142","repostId":"1146715547","repostType":2,"isVote":1,"tweetType":1,"viewCount":1679,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872990577,"gmtCreate":1637384144658,"gmtModify":1637384448297,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"Like like like&nbsp;","listText":"Like like like&nbsp;","text":"Like like like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/872990577","repostId":"1120617526","repostType":2,"isVote":1,"tweetType":1,"viewCount":733,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878049207,"gmtCreate":1637129041957,"gmtModify":1637129217128,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"Very hard to select a good stock with good returns&nbsp;","listText":"Very hard to select a good stock with good returns&nbsp;","text":"Very hard to select a good stock with good returns","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878049207","repostId":"1185179037","repostType":2,"isVote":1,"tweetType":1,"viewCount":652,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879911270,"gmtCreate":1636676073644,"gmtModify":1636676073853,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>up up up","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>up up up","text":"$Tiger Brokers(TIGR)$up up up","images":[{"img":"https://static.tigerbbs.com/37b95cd096ef6bc8c4aa0d2ec19e132e","width":"1080","height":"3660"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/879911270","isVote":1,"tweetType":1,"viewCount":305,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":823735793,"gmtCreate":1633660376616,"gmtModify":1633660376810,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"High will be higer","listText":"High will be higer","text":"High will be higer","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/823735793","repostId":"1132313077","repostType":4,"repost":{"id":"1132313077","kind":"news","pubTimestamp":1633659722,"share":"https://ttm.financial/m/news/1132313077?lang=&edition=full","pubTime":"2021-10-08 10:22","market":"us","language":"en","title":"Tesla Is on a Path to $400 Billion in Sales. Thank GM.","url":"https://stock-news.laohu8.com/highlight/detail?id=1132313077","media":"Barrons","summary":"Electric vehicles are winning.\nTraditional auto makers are going all in on electric vehicles, spendi","content":"<p></p>\n<p>Electric vehicles are winning.</p>\n<p>Traditional auto makers are going all in on electric vehicles, spending billions to develop models and build battery plants. They are all, essentially, chasing&nbsp;Tesla&nbsp;(ticker: TSLA).</p>\n<p>Wednesday,General Motors&nbsp;(GM) outlined plans to double annual sales by 2030. EVs play a huge role. By then GM wants to have leading EV share and sell $90 billion worth of EVs in that year.</p>\n<p>If GM pulls it off, its stock should soar. But if GM hits its goals, then Tesla should be, frankly, an enormous company by then, too. Here’s the math.</p>\n<p>GM believes that 40% to 50% of U.S. new car sales in 2030 will be all electric. That will amount to, perhaps, 10 million EVs sold. With normal inflation, that will work out to about $500 billion in U.S. EV sales.</p>\n<p>Total U.S car sales in 2030 might amount to $900 billion. U.S. car sales topped $460 billion in pre-pandemic 2019. The average annual growth rate implied by that forecast is about 6%. That seems sensible. The average car price rises about 4% a year, and car volumes rise as the country grows–there are more drivers. Still, all of these numbers are only approximations.</p>\n<p>So GM plans to have about 18% of U.S. EV market share by the end of the decade. Tesla has more than 60% U.S. market share now. If Tesla manages to keep its market share lead it can generate, perhaps, $100 billion in U.S. sales from selling roughly 2 million units.</p>\n<p>Tesla, however, generates more of its sales overseas. Europe and China have been faster to adopt EVs. If Tesla is generating $100 billion in U.S. sales, total EV sales should top $250 billion.</p>\n<p>There is one other factor to consider with an auto company: size.</p>\n<p>The GM strategy to double sales relies on GM transforming itself into a platform company with multiple lines of revenue. That’s also a little like Tesla. Elon Musk’s company sells insurance, software subscriptions for self driving car features, stationary power for residential consumers and utilities as well as solar roofs, not to mention Tesla owns a charging station network.</p>\n<p>GM wants to generate roughly $80 billion or $90 billion from its new, ancillary businesses, including insurance and self driving cars among others. That amounts to about 30% of the company’s 2030 annual goal. Tesla does a little more than GM, so if Tesla’s income statement looks similar, in terms of revenue mix, Tesla might be generating 40% of its sales from other lines and generating roughly $400 billion to $420 billion in sales.</p>\n<p>Tesla is expected to generate roughly $50 billion in sales in 2021. If that math is close, Tesla’s average annual sales growth will amount to about 26% a year between now and then.</p>\n<p>Not bad.</p>\n<p>The farthest Wall Street goes out for Tesla sales estimates is about 2026. In that year analysts project about $140 billion in sales. That’s a growth rate, between 2021 and 2026, of about 23% a year. That’s probably a little low, however.</p>\n<p>Longer-term estimates for analysts aren’t very reliable. What’s more, not everyone publishes long-term forecasts. The number of analysts projecting long-term revenue is less than the total number of analysts covering the stock. Analysts, for the most part, put most of their energy on sales estimates one or two years out, even when they expect growth to last far in the future.</p>\n<p>Looking ahead, what investors need to ask is if GM’s vision of the future is correct, what does it mean for all auto stocks.</p>\n<p>GM, of course, isn’t valued like a growth stock. It trades for less than 8 times estimated 2022 earnings. Tesla trades for about 100 times that amount.</p>\n<p>Given that valuation discrepancy, investors aren’t sure what to make of GM’s vision yet.</p>\n<p>GM stock rose 4.7% on Thursday. The&nbsp;S&amp;P 500&nbsp;and&nbsp;Dow Jones Industrial Average&nbsp;rose 0.8% and 1%, respectively. Tesla shares have added 1.4%.</p>\n<p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Is on a Path to $400 Billion in Sales. Thank GM.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Is on a Path to $400 Billion in Sales. Thank GM.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-08 10:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/tesla-stock-price-sales-general-motors-51633623910?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Electric vehicles are winning.\nTraditional auto makers are going all in on electric vehicles, spending billions to develop models and build battery plants. They are all, essentially, chasing Tesla (...</p>\n\n<a href=\"https://www.barrons.com/articles/tesla-stock-price-sales-general-motors-51633623910?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.barrons.com/articles/tesla-stock-price-sales-general-motors-51633623910?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132313077","content_text":"Electric vehicles are winning.\nTraditional auto makers are going all in on electric vehicles, spending billions to develop models and build battery plants. They are all, essentially, chasing Tesla (ticker: TSLA).\nWednesday,General Motors (GM) outlined plans to double annual sales by 2030. EVs play a huge role. By then GM wants to have leading EV share and sell $90 billion worth of EVs in that year.\nIf GM pulls it off, its stock should soar. But if GM hits its goals, then Tesla should be, frankly, an enormous company by then, too. Here’s the math.\nGM believes that 40% to 50% of U.S. new car sales in 2030 will be all electric. That will amount to, perhaps, 10 million EVs sold. With normal inflation, that will work out to about $500 billion in U.S. EV sales.\nTotal U.S car sales in 2030 might amount to $900 billion. U.S. car sales topped $460 billion in pre-pandemic 2019. The average annual growth rate implied by that forecast is about 6%. That seems sensible. The average car price rises about 4% a year, and car volumes rise as the country grows–there are more drivers. Still, all of these numbers are only approximations.\nSo GM plans to have about 18% of U.S. EV market share by the end of the decade. Tesla has more than 60% U.S. market share now. If Tesla manages to keep its market share lead it can generate, perhaps, $100 billion in U.S. sales from selling roughly 2 million units.\nTesla, however, generates more of its sales overseas. Europe and China have been faster to adopt EVs. If Tesla is generating $100 billion in U.S. sales, total EV sales should top $250 billion.\nThere is one other factor to consider with an auto company: size.\nThe GM strategy to double sales relies on GM transforming itself into a platform company with multiple lines of revenue. That’s also a little like Tesla. Elon Musk’s company sells insurance, software subscriptions for self driving car features, stationary power for residential consumers and utilities as well as solar roofs, not to mention Tesla owns a charging station network.\nGM wants to generate roughly $80 billion or $90 billion from its new, ancillary businesses, including insurance and self driving cars among others. That amounts to about 30% of the company’s 2030 annual goal. Tesla does a little more than GM, so if Tesla’s income statement looks similar, in terms of revenue mix, Tesla might be generating 40% of its sales from other lines and generating roughly $400 billion to $420 billion in sales.\nTesla is expected to generate roughly $50 billion in sales in 2021. If that math is close, Tesla’s average annual sales growth will amount to about 26% a year between now and then.\nNot bad.\nThe farthest Wall Street goes out for Tesla sales estimates is about 2026. In that year analysts project about $140 billion in sales. That’s a growth rate, between 2021 and 2026, of about 23% a year. That’s probably a little low, however.\nLonger-term estimates for analysts aren’t very reliable. What’s more, not everyone publishes long-term forecasts. The number of analysts projecting long-term revenue is less than the total number of analysts covering the stock. Analysts, for the most part, put most of their energy on sales estimates one or two years out, even when they expect growth to last far in the future.\nLooking ahead, what investors need to ask is if GM’s vision of the future is correct, what does it mean for all auto stocks.\nGM, of course, isn’t valued like a growth stock. It trades for less than 8 times estimated 2022 earnings. Tesla trades for about 100 times that amount.\nGiven that valuation discrepancy, investors aren’t sure what to make of GM’s vision yet.\nGM stock rose 4.7% on Thursday. The S&P 500 and Dow Jones Industrial Average rose 0.8% and 1%, respectively. Tesla shares have added 1.4%.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":379,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846801212,"gmtCreate":1636070968757,"gmtModify":1636079798739,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/G13.SI\">$GENTING SINGAPORE LIMITED(G13.SI)$</a>casino or resort&nbsp;","listText":"<a href=\"https://laohu8.com/S/G13.SI\">$GENTING SINGAPORE LIMITED(G13.SI)$</a>casino or resort&nbsp;","text":"$GENTING SINGAPORE LIMITED(G13.SI)$casino or resort","images":[{"img":"https://static.tigerbbs.com/a879272ebfcf8aa5e4182d659a497765","width":"1080","height":"3444"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/846801212","isVote":1,"tweetType":1,"viewCount":854,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":878040585,"gmtCreate":1637128973354,"gmtModify":1637129213996,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"Like like like&nbsp;","listText":"Like like like&nbsp;","text":"Like like like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878040585","repostId":"1143997581","repostType":2,"repost":{"id":"1143997581","kind":"news","pubTimestamp":1637117047,"share":"https://ttm.financial/m/news/1143997581?lang=&edition=full","pubTime":"2021-11-17 10:44","market":"us","language":"en","title":"Palantir Stock: What’s Next as The Meme Crowd Follows Wall Street’s Lead?","url":"https://stock-news.laohu8.com/highlight/detail?id=1143997581","media":"Thestreet","summary":"Shares in analytics software company Palantir(PLTR) have been resilient, even though Wall Street ana","content":"<p>Shares in analytics software company Palantir(<b>PLTR</b>)&nbsp;have been resilient, even though Wall Street analysts were&nbsp;beginning to question the sustainability of its high rate of growth. Retail investors, in particular those associated with Reddit’s r/WallStreetBets trading community, remained bullish on the stock.</p>\n<p>However, after the company’s recent earnings release, this may be starting to change.Discussions about PLTR on r/WSB have fallen considerably. Without the meme crowd to bolster it, could another big drop be in the cards? Let’s dive in and find out what’s next for this former meme favorite.</p>\n<p>PLTR Stock, Earnings, and The Market’s Response</p>\n<p>On November 9, Palantir reported its results for the quarter ending September 30. For the period, ittopped revenue estimates, generating $392 million in sales, versus analyst consensus of $385 million.</p>\n<p>The company also delivered earnings per share (EPS) of 4 cents, in line with expectations. Its latest updates to its revenue outlook were also positive. Guidance for Q4 2021 is now $418 million, versus $402 million projected by the sell-side community. For the full year 2021, it expects to post $1.53 billion – in other words, year-over-year revenue growth of 40%.</p>\n<p>Nevertheless, instead of popping on the news, shares dropped, resulting in a 9.4% dip on November 9 alone, and a 7.1% decline the following day. While PLTR traded for just under $27 per share ahead of earnings, it is now worth around $22.83 per share.</p>\n<p>So, is the drop the result of investors “selling the news?” To some extent, perhaps. But besides the latest earnings report, there’s been another development that has weighed on shares: an analyst downgrade that dropped shortly after earnings.</p>\n<p>Why The Latest Analyst Downgrade May Signal a Bumpy Road Ahead</p>\n<p>On November 10, RBC Capital’s Rishi Jaluriareleased his newest rating on PLTR stock. His take was a brutal one. After downgrading shares and lowering the price target, Jaluria is now worried about two things.</p>\n<p>The first is a slowdown in growth in the company’s key governmental services business. The increase in revenue from U.S. Federal contracts have fallen by half quarter-over-quarter. Second, Jaluria believes that the company’s commercial growth, which has accelerated, is largely driven by the company’s SPAC (special purpose acquisition company) investments.</p>\n<p>According to the RBC analyst, without these deals, where the SPAC acquisition target signs on as a Palantir client, the company would have posted much lower commercial sales growth. All in all, the analyst is doubtful that the company can sustain a 30%+ rate of growth going forward.</p>\n<p>This of course isn’t the first time someone from the sell-side has called out the company and its growth projections. But it appears that Main Street is open to following Wall Street’s bearish lead at last. The road ahead for PLTR stock may become bumpier.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir Stock: What’s Next as The Meme Crowd Follows Wall Street’s Lead?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir Stock: What’s Next as The Meme Crowd Follows Wall Street’s Lead?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-17 10:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/memestocks/other-memes/palantir-stock-whats-next-as-the-meme-crowd-follows-wall-streets-lead><strong>Thestreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares in analytics software company Palantir(PLTR) have been resilient, even though Wall Street analysts were beginning to question the sustainability of its high rate of growth. Retail investors, in...</p>\n\n<a href=\"https://www.thestreet.com/memestocks/other-memes/palantir-stock-whats-next-as-the-meme-crowd-follows-wall-streets-lead\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://www.thestreet.com/memestocks/other-memes/palantir-stock-whats-next-as-the-meme-crowd-follows-wall-streets-lead","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143997581","content_text":"Shares in analytics software company Palantir(PLTR) have been resilient, even though Wall Street analysts were beginning to question the sustainability of its high rate of growth. Retail investors, in particular those associated with Reddit’s r/WallStreetBets trading community, remained bullish on the stock.\nHowever, after the company’s recent earnings release, this may be starting to change.Discussions about PLTR on r/WSB have fallen considerably. Without the meme crowd to bolster it, could another big drop be in the cards? Let’s dive in and find out what’s next for this former meme favorite.\nPLTR Stock, Earnings, and The Market’s Response\nOn November 9, Palantir reported its results for the quarter ending September 30. For the period, ittopped revenue estimates, generating $392 million in sales, versus analyst consensus of $385 million.\nThe company also delivered earnings per share (EPS) of 4 cents, in line with expectations. Its latest updates to its revenue outlook were also positive. Guidance for Q4 2021 is now $418 million, versus $402 million projected by the sell-side community. For the full year 2021, it expects to post $1.53 billion – in other words, year-over-year revenue growth of 40%.\nNevertheless, instead of popping on the news, shares dropped, resulting in a 9.4% dip on November 9 alone, and a 7.1% decline the following day. While PLTR traded for just under $27 per share ahead of earnings, it is now worth around $22.83 per share.\nSo, is the drop the result of investors “selling the news?” To some extent, perhaps. But besides the latest earnings report, there’s been another development that has weighed on shares: an analyst downgrade that dropped shortly after earnings.\nWhy The Latest Analyst Downgrade May Signal a Bumpy Road Ahead\nOn November 10, RBC Capital’s Rishi Jaluriareleased his newest rating on PLTR stock. His take was a brutal one. After downgrading shares and lowering the price target, Jaluria is now worried about two things.\nThe first is a slowdown in growth in the company’s key governmental services business. The increase in revenue from U.S. Federal contracts have fallen by half quarter-over-quarter. Second, Jaluria believes that the company’s commercial growth, which has accelerated, is largely driven by the company’s SPAC (special purpose acquisition company) investments.\nAccording to the RBC analyst, without these deals, where the SPAC acquisition target signs on as a Palantir client, the company would have posted much lower commercial sales growth. All in all, the analyst is doubtful that the company can sustain a 30%+ rate of growth going forward.\nThis of course isn’t the first time someone from the sell-side has called out the company and its growth projections. But it appears that Main Street is open to following Wall Street’s bearish lead at last. The road ahead for PLTR stock may become bumpier.","news_type":1,"symbols_score_info":{"PLTR":0.9}},"isVote":1,"tweetType":1,"viewCount":363,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870818591,"gmtCreate":1636599349413,"gmtModify":1636599349482,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C76.SI\">$CREATIVE TECHNOLOGY LTD(C76.SI)$</a>was $60+ when everyone thought Mr Sim is talent","listText":"<a href=\"https://laohu8.com/S/C76.SI\">$CREATIVE TECHNOLOGY LTD(C76.SI)$</a>was $60+ when everyone thought Mr Sim is talent","text":"$CREATIVE TECHNOLOGY LTD(C76.SI)$was $60+ when everyone thought Mr Sim is talent","images":[{"img":"https://static.tigerbbs.com/4a89fd5684639971a8c9cd2582795b0b","width":"1080","height":"3444"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/870818591","isVote":1,"tweetType":1,"viewCount":356,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":843197380,"gmtCreate":1635811804175,"gmtModify":1635811804175,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>is this price a buy for long term?","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>is this price a buy for long term?","text":"$Apple(AAPL)$is this price a buy for long term?","images":[{"img":"https://static.tigerbbs.com/c0361bd7f41b887c3725f7ec8a43cd8b","width":"1080","height":"3543"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843197380","isVote":1,"tweetType":1,"viewCount":605,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":849195135,"gmtCreate":1635733206649,"gmtModify":1635733206649,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/1AZ.SI\">$Audience(1AZ.SI)$</a>Malaysian stock listed in SGX market.&nbsp;","listText":"<a href=\"https://laohu8.com/S/1AZ.SI\">$Audience(1AZ.SI)$</a>Malaysian stock listed in SGX market.&nbsp;","text":"$Audience(1AZ.SI)$Malaysian stock listed in SGX market.","images":[{"img":"https://static.tigerbbs.com/da5afd7a9b1bb182d27f59bf92546d68","width":"1080","height":"3444"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/849195135","isVote":1,"tweetType":1,"viewCount":902,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":855019689,"gmtCreate":1635312540540,"gmtModify":1635312540540,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OMK.SI\">$VIVIDTHREE HOLDINGS LTD.(OMK.SI)$</a>crazy stock market&nbsp;","listText":"<a href=\"https://laohu8.com/S/OMK.SI\">$VIVIDTHREE HOLDINGS LTD.(OMK.SI)$</a>crazy stock market&nbsp;","text":"$VIVIDTHREE HOLDINGS LTD.(OMK.SI)$crazy stock market","images":[{"img":"https://static.tigerbbs.com/e795dcca08728bd35484d43ce72ccff8","width":"1080","height":"3444"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/855019689","isVote":1,"tweetType":1,"viewCount":889,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":856087042,"gmtCreate":1635130239226,"gmtModify":1635130239445,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C13.SI\">$CH OFFSHORE LTD(C13.SI)$</a>the stock related to Baker Tech.&nbsp; Both are oil and gas industry&nbsp;","listText":"<a href=\"https://laohu8.com/S/C13.SI\">$CH OFFSHORE LTD(C13.SI)$</a>the stock related to Baker Tech.&nbsp; Both are oil and gas industry&nbsp;","text":"$CH OFFSHORE LTD(C13.SI)$the stock related to Baker Tech. Both are oil and gas industry","images":[{"img":"https://static.tigerbbs.com/daaa911c825e4bb6f5ac2cb35cc3293a","width":"1080","height":"3444"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/856087042","isVote":1,"tweetType":1,"viewCount":288,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":851761449,"gmtCreate":1634946388998,"gmtModify":1634946389178,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/42W.SI\">$CHINA STAR FOOD GROUP LIMITED(42W.SI)$</a>waiting a announcement to push","listText":"<a href=\"https://laohu8.com/S/42W.SI\">$CHINA STAR FOOD GROUP LIMITED(42W.SI)$</a>waiting a announcement to push","text":"$CHINA STAR FOOD GROUP LIMITED(42W.SI)$waiting a announcement to push","images":[{"img":"https://static.tigerbbs.com/ac73e6996323209732b05e4997f9dca2","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/851761449","isVote":1,"tweetType":1,"viewCount":325,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":827786581,"gmtCreate":1634523996526,"gmtModify":1634524005136,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"I am using their One Credit Card","listText":"I am using their One Credit Card","text":"I am using their One Credit Card","images":[{"img":"https://static.tigerbbs.com/5d00edfbde36182d9c9189cb4dcf296f","width":"1080","height":"3444"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/827786581","isVote":1,"tweetType":1,"viewCount":298,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":699286765,"gmtCreate":1639811078351,"gmtModify":1639811078503,"author":{"id":"4094271228114110","authorId":"4094271228114110","name":"NG1970","avatar":"https://static.tigerbbs.com/a6cddc817b4e919217e1b8d46fbad4ac","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094271228114110","idStr":"4094271228114110"},"themes":[],"htmlText":"Like like like&nbsp;","listText":"Like like like&nbsp;","text":"Like like like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699286765","repostId":"2192971353","repostType":2,"isVote":1,"tweetType":1,"viewCount":1431,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}